ONTOLOGY REPORT - ANNOTATIONS
| Term: | Endocrine System Diseases |
|
| Accession: | RDO:0004756
|
browse the term
|
| Definition: | Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES. |
| Synonyms: | exact_synonym: | Diseases of Endocrine System; Endocrine Disease; Endocrine Diseases; Endocrine System Disease |
| | primary_id: | MESH:D004700 |
|
|
Diabetes Complications
|
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
|
ISS |
20 |
4,250,613 |
4,253,540 |
RGD:6767555 |
RGD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
|
ISS |
1 |
243,281,320 |
243,320,945 |
RGD:2307154 |
RGD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
|
ISS |
1 |
21,223,678 |
21,287,411 |
RGD:6906933 |
RGD |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
|
ISS |
4 |
149,622,566 |
149,628,111 |
RGD:7242563 |
RGD |
| G |
Glo1 |
glyoxalase 1 |
|
No_Association |
ISS |
20 |
8,900,984 |
8,919,001 |
RGD:7242569 |
RGD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
|
IED |
2 |
54,327,821 |
54,360,462 |
RGD:6484542 |
RGD |
| G |
Slc9a1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
|
IPM |
5 |
151,680,696 |
151,748,460 |
RGD:6771339 |
RGD |
Diabetes Mellitus
|
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
|
ISS |
1 |
96,622,574 |
96,703,723 |
RGD:1625279 |
RGD |
| G |
Acp1 |
acid phosphatase 1, soluble |
|
|
ISS |
6 |
48,784,243 |
48,798,868 |
RGD:2313188 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISS |
1 |
82,686,233 |
82,726,544 |
RGD:2313408 |
RGD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
|
ISS |
5 |
66,283,165 |
66,296,171 |
RGD:2313440 |
RGD |
| G |
Apob |
apolipoprotein B |
|
|
ISS |
6 |
31,508,060 |
31,548,083 |
RGD:2313973 |
RGD |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
ISS |
1 |
78,979,034 |
78,984,002 |
RGD:2313973 |
RGD |
| G |
Apoc3 |
apolipoprotein C-III |
|
|
ISS |
|
|
|
RGD:2313973 |
RGD |
| G |
Apoh |
apolipoprotein H (beta-2-glycoprotein I) |
|
|
ISS |
10 |
97,725,088 |
97,739,213 |
RGD:2313991 |
RGD |
| G |
Apoh |
apolipoprotein H (beta-2-glycoprotein I) |
|
|
ISS |
10 |
97,725,088 |
97,739,213 |
RGD:2313982 |
RGD |
| G |
Aqp1 |
aquaporin 1 |
|
|
IEP |
4 |
84,098,346 |
84,110,524 |
RGD:2316076 |
RGD |
| G |
Aqp4 |
aquaporin 4 |
|
|
IEP |
18 |
6,626,313 |
6,642,766 |
RGD:2316076 |
RGD |
| G |
Asip |
agouti signaling protein |
|
|
ISS |
3 |
145,445,175 |
145,536,831 |
RGD:2314006 |
RGD |
| G |
Cat |
catalase |
|
|
ISS |
3 |
88,654,077 |
88,686,212 |
RGD:7240710 |
OMIM |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:2307062 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
ISS |
4 |
13,471,878 |
13,525,620 |
RGD:2307209 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
ISS |
X |
141,925,019 |
141,937,183 |
RGD:2314209 |
RGD |
| G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
|
|
ISS |
17 |
41,208,037 |
41,259,863 |
RGD:2313940 |
RGD |
| G |
Cpb2 |
carboxypeptidase B2 (plasma) |
|
|
ISS |
15 |
56,104,920 |
56,154,321 |
RGD:2313643 |
RGD |
| G |
Ctsb |
cathepsin B |
|
Onset |
ISS |
15 |
42,402,829 |
42,423,701 |
RGD:2315528 |
RGD |
| G |
Cyb5r4 |
cytochrome b5 reductase 4 |
|
|
ISS |
8 |
92,278,453 |
92,343,490 |
RGD:2315644 |
RGD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
Susceptibility |
ISS |
7 |
113,043,365 |
113,049,779 |
RGD:2307297 |
RGD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
|
ISS |
8 |
61,462,207 |
61,468,237 |
RGD:2307073 |
RGD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
|
ISS |
2 |
218,371,050 |
218,382,645 |
RGD:2313869 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
No_Association |
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312391 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
IED |
16 |
81,348,678 |
81,358,991 |
RGD:2312393 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
IEP |
16 |
81,348,678 |
81,358,991 |
RGD:1598920 |
RGD |
| G |
Fn1 |
fibronectin 1 |
|
|
ISS |
9 |
70,702,181 |
70,771,155 |
RGD:7206845 |
RGD |
| G |
Fuca1 |
fucosidase, alpha-L- 1, tissue |
|
|
ISS |
5 |
154,703,722 |
154,720,971 |
RGD:2315945 |
RGD |
| G |
Fxn |
frataxin |
|
|
ISS |
1 |
227,647,092 |
227,671,081 |
RGD:2307048 |
RGD |
| G |
Fxn |
frataxin |
|
|
ISS |
1 |
227,647,092 |
227,671,081 |
RGD:2307047 |
RGD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
|
IED |
3 |
52,789,370 |
52,830,038 |
RGD:728511 |
RGD |
| G |
Gc |
group specific component |
|
|
ISS |
14 |
20,166,243 |
20,197,060 |
RGD:5509921 |
RGD |
| G |
Gck |
glucokinase |
|
|
ISS |
14 |
86,572,518 |
86,587,723 |
RGD:1601295 |
RGD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
|
ISS |
|
|
|
RGD:2315601 |
RGD |
| G |
Gh1 |
growth hormone 1 |
|
|
ISS |
10 |
95,692,240 |
95,694,117 |
RGD:2315653 |
RGD |
| G |
Gh1 |
growth hormone 1 |
|
|
ISS |
10 |
95,692,240 |
95,694,117 |
RGD:2315658 |
RGD |
| G |
Gipr |
gastric inhibitory polypeptide receptor |
|
|
ISS |
1 |
78,515,051 |
78,526,160 |
RGD:2312617 |
RGD |
| G |
Glp1r |
glucagon-like peptide 1 receptor |
|
|
TAS |
20 |
9,225,881 |
9,264,184 |
RGD:625448 |
RGD |
| G |
Gnb3 |
guanine nucleotide binding protein (G protein), beta polypeptide 3 |
|
No_Association |
ISS |
4 |
160,957,524 |
160,963,226 |
RGD:2313206 |
RGD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
|
ISS |
10 |
40,311,094 |
40,319,382 |
RGD:2312632 |
RGD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
|
ISS |
10 |
40,311,094 |
40,319,382 |
RGD:2312633 |
RGD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
Susceptibility |
ISS |
2 |
203,575,444 |
203,580,821 |
RGD:2306632 |
RGD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
Susceptibility |
ISS |
20 |
13,604,355 |
13,621,456 |
RGD:5490997 |
RGD |
| G |
Hgf |
hepatocyte growth factor |
|
|
ISS |
4 |
14,864,357 |
14,932,513 |
RGD:2313569 |
RGD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
|
ISS |
2 |
27,127,504 |
27,149,580 |
RGD:2313755 |
RGD |
| G |
Hp |
haptoglobin |
|
|
ISS |
19 |
39,443,016 |
39,447,566 |
RGD:1626347 |
RGD |
| G |
Ica1 |
islet cell autoantigen 1 |
|
|
IED |
4 |
33,680,878 |
33,830,443 |
RGD:633043 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:2313467 |
RGD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
ISS |
1 |
122,704,976 |
122,990,007 |
RGD:2311506 |
RGD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
|
IPM |
17 |
78,050,491 |
78,097,802 |
RGD:2311530 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307180 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307273 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307278 |
RGD |
| G |
Il6 |
interleukin 6 |
|
Susceptibility |
ISS |
4 |
456,799 |
461,376 |
RGD:2307293 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2311109 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2311115 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317259 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317262 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317260 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISS |
12 |
2,934,967 |
3,087,691 |
RGD:2307334 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISS |
12 |
2,934,967 |
3,087,691 |
RGD:2307343 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISS |
12 |
2,934,967 |
3,087,691 |
RGD:2307335 |
RGD |
| G |
Insr |
insulin receptor |
|
|
IAGP |
12 |
2,934,967 |
3,087,691 |
RGD:2307334 |
RGD |
| G |
Insr |
insulin receptor |
|
|
IAGP |
12 |
2,934,967 |
3,087,691 |
RGD:2307341 |
RGD |
| G |
Itga2 |
integrin, alpha 2 |
|
|
ISS |
2 |
46,967,681 |
47,080,909 |
RGD:2307424 |
RGD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
Susceptibility |
ISS |
4 |
143,705,360 |
144,030,051 |
RGD:6480678 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:1625279 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:2311536 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:1625256 |
RGD |
| G |
Mt-nd4l |
mitochondrially encoded NADH 4L |
|
|
ISS |
MT |
9,870 |
10,166 |
RGD:5686343 |
RGD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
|
ISS |
16 |
23,855,555 |
23,876,531 |
RGD:2311597 |
RGD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
|
IEP |
5 |
151,524,685 |
151,528,000 |
RGD:2311606 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
ISS |
|
|
|
RGD:2308812 |
RGD |
| G |
Prom1 |
prominin 1 |
|
|
IED |
14 |
72,122,986 |
72,230,453 |
RGD:68837 |
RGD |
| G |
Pten |
phosphatase and tensin homolog |
|
|
IEP |
1 |
236,771,027 |
236,837,261 |
RGD:2292543 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:5143927 |
RGD |
| G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
|
|
ISS |
2 |
199,083,186 |
199,144,309 |
RGD:6484729 |
RGD |
| G |
Serpina7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
|
ISS |
X |
126,739,203 |
126,744,763 |
RGD:2312329 |
RGD |
| G |
Shbg |
sex hormone binding globulin |
|
|
ISS |
10 |
56,432,474 |
56,435,654 |
RGD:2313784 |
RGD |
| G |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
|
|
ISS |
13 |
80,017,780 |
80,031,777 |
RGD:1599325 |
RGD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
|
ISS |
4 |
159,210,116 |
159,221,169 |
RGD:2313619 |
RGD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
|
ISS |
14 |
63,381,447 |
63,387,180 |
RGD:1581299 |
RGD |
| G |
Srd5a2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
|
IEP |
6 |
21,453,521 |
21,489,408 |
RGD:1600067 |
RGD |
| G |
Tcf7l2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
|
ISS |
1 |
262,031,823 |
262,226,710 |
RGD:2312417 |
RGD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
|
ISS |
X |
12,542,496 |
12,547,094 |
RGD:2312464 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:2312485 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:1580736 |
RGD |
| G |
Tnfrsf8 |
tumor necrosis factor receptor superfamily, member 8 |
|
|
ISS |
5 |
163,716,462 |
163,762,235 |
RGD:2312735 |
RGD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
|
ISS |
1 |
157,896,001 |
157,909,608 |
RGD:2313514 |
RGD |
| G |
Vwf |
von Willebrand factor |
|
Treatment |
ISS |
4 |
161,723,415 |
161,854,766 |
RGD:7207029 |
RGD |
| Q |
Gluco35 |
Glucose level QTL 35 |
|
|
IAGP |
3 |
79,283,621 |
114,574,752 |
RGD:2298688 |
RGD |
| Q |
Gluco36 |
Glucose level QTL 36 |
|
|
IAGP |
8 |
30,878,636 |
53,049,477 |
RGD:2298688 |
RGD |
| Q |
Gluco37 |
Glucose level QTL 37 |
|
|
IAGP |
13 |
1,265,159 |
47,698,301 |
RGD:2298688 |
RGD |
| Q |
Gluco38 |
Glucose level QTL 38 |
|
|
IAGP |
14 |
12,386,493 |
30,087,990 |
RGD:2298688 |
RGD |
| Q |
Iddm15 |
Insulin dependent diabetes mellitus QTL 15 |
|
|
IAGP |
|
|
|
RGD:619685 |
RGD |
| S |
ACI.BBDP-(RT1u),(Gimap5)/Sunn |
|
|
Spontaneous |
IAGP |
|
|
|
RGD:2293011 |
RGD |
| S |
CD |
Cohen diabetic rat |
|
|
QTM |
|
|
|
RGD:1354520 |
RGD |
| S |
SD-Tg(Insr-shRNA)14Bdr |
|
|
Model |
IED |
|
|
|
RGD:2307333 |
RGD |
| S |
SD-Tg(Insr-shRNA)29Bdr |
|
|
Model |
IED |
|
|
|
RGD:2307333 |
RGD |
| S |
SDT/CrljJcl |
|
|
Model |
TAS |
|
|
|
RGD:2298688 |
RGD |
| S |
SDT/CrljJcl |
|
|
|
TAS |
|
|
|
RGD:628479 |
RGD |
Diabetes Mellitus, Lipoatrophic
|
| G |
Insr |
insulin receptor |
|
|
ISS |
12 |
2,934,967 |
3,087,691 |
RGD:1302525 |
RGD |
| G |
Lmna |
lamin A/C |
|
|
ISS |
2 |
180,595,724 |
180,616,354 |
RGD:1580516 |
RGD |
Diabetes Mellitus, Type 2
|
| G |
Aanat |
aralkylamine N-acetyltransferase |
|
|
IED |
10 |
106,709,371 |
106,713,683 |
RGD:2301037 |
RGD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
Onset |
ISS |
5 |
70,493,357 |
70,583,729 |
RGD:2312576 |
RGD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
|
ISS |
4 |
21,709,855 |
21,796,628 |
RGD:2312331 |
RGD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
|
IED |
|
|
|
RGD:2312736 |
RGD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
|
ISS |
|
|
|
RGD:2312726 |
RGD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
Susceptibility |
ISS |
1 |
96,622,574 |
96,703,723 |
RGD:2301901 |
RGD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
|
ISS |
1 |
96,622,574 |
96,703,723 |
RGD:2313628 |
RGD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
|
ISS |
1 |
96,622,574 |
96,703,723 |
RGD:737750 |
RGD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
|
ISS |
1 |
96,622,574 |
96,703,723 |
RGD:2301898 |
RGD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
Susceptibility |
ISS |
1 |
96,622,574 |
96,703,723 |
RGD:1598640 |
RGD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
|
ISS |
1 |
96,622,574 |
96,703,723 |
RGD:2301897 |
RGD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
|
ISS |
1 |
96,622,574 |
96,703,723 |
RGD:7240710 |
OMIM |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
IEA |
10 |
95,361,338 |
95,381,455 |
RGD:1331525 |
RGD |
| G |
Acot2 |
acyl-CoA thioesterase 2 |
|
|
IED |
6 |
108,017,574 |
108,024,387 |
RGD:1625728 |
RGD |
| G |
Acp1 |
acid phosphatase 1, soluble |
|
|
ISS |
6 |
48,784,243 |
48,798,868 |
RGD:2313183 |
RGD |
| G |
Ada |
adenosine deaminase |
|
|
ISS |
3 |
154,636,530 |
154,660,637 |
RGD:2313539 |
RGD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
|
ISS |
6 |
41,882,432 |
41,930,755 |
RGD:2313250 |
RGD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
|
ISS |
6 |
41,882,432 |
41,930,755 |
RGD:2312470 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
IEP |
11 |
79,908,291 |
79,911,065 |
RGD:5686359 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686752 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:2313238 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:2313230 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686807 |
RGD |
| G |
Adipor1 |
adiponectin receptor 1 |
|
|
ISS |
13 |
47,358,625 |
47,379,565 |
RGD:1331376 |
RGD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
|
ISS |
4 |
155,664,035 |
155,677,627 |
RGD:2312490 |
RGD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
No_Association |
ISS |
4 |
155,664,035 |
155,677,627 |
RGD:2312476 |
RGD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
|
ISS |
4 |
155,664,035 |
155,677,627 |
RGD:2312480 |
RGD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
|
ISS |
4 |
155,664,035 |
155,677,627 |
RGD:2312486 |
RGD |
| G |
Adm |
adrenomedullin |
|
|
ISS |
1 |
168,380,255 |
168,382,426 |
RGD:2313313 |
RGD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
Susceptibility |
ISS |
|
|
|
RGD:2316628 |
RGD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
|
IEP |
|
|
|
RGD:2316628 |
RGD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
Onset |
ISS |
3 |
114,867,357 |
114,869,680 |
RGD:2313544 |
RGD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
|
ISS |
3 |
114,867,357 |
114,869,680 |
RGD:2313543 |
RGD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
No_Association |
ISS |
18 |
58,174,958 |
58,177,000 |
RGD:1601119 |
RGD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
|
IEA |
18 |
58,174,958 |
58,177,000 |
RGD:1331525 |
RGD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
Onset |
ISS |
16 |
69,163,620 |
69,166,384 |
RGD:2313163 |
RGD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
Susceptibility |
ISS |
16 |
69,163,620 |
69,166,384 |
RGD:2313149 |
RGD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
No_Association |
ISS |
16 |
69,163,620 |
69,166,384 |
RGD:2313148 |
RGD |
| G |
Agrp |
agouti related protein homolog (mouse) |
|
|
ISS |
19 |
35,386,682 |
35,388,274 |
RGD:2314000 |
RGD |
| G |
Agrp |
agouti related protein homolog (mouse) |
|
|
IEP |
19 |
35,386,682 |
35,388,274 |
RGD:2311538 |
RGD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
|
ISS |
19 |
54,738,556 |
54,750,349 |
RGD:1601138 |
RGD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
|
IEP |
|
|
|
RGD:2313550 |
RGD |
| G |
Ahsg |
alpha-2-HS-glycoprotein |
|
Susceptibility |
ISS |
11 |
80,330,615 |
80,336,658 |
RGD:2313812 |
RGD |
| G |
Ahsg |
alpha-2-HS-glycoprotein |
|
|
ISS |
11 |
80,330,615 |
80,336,658 |
RGD:2313811 |
RGD |
| G |
Ak1 |
adenylate kinase 1 |
|
|
IEP |
2 |
19,821,482 |
19,822,544 |
RGD:5134362 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
IED |
6 |
137,640,482 |
137,657,552 |
RGD:2313556 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISS |
6 |
137,640,482 |
137,657,552 |
RGD:2311130 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISS |
1 |
82,686,233 |
82,726,544 |
RGD:2313405 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISS |
1 |
82,686,233 |
82,726,544 |
RGD:2307342 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISS |
1 |
82,686,233 |
82,726,544 |
RGD:2311130 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISS |
1 |
82,686,233 |
82,726,544 |
RGD:734545 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISS |
1 |
82,686,233 |
82,726,544 |
RGD:7240710 |
OMIM |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
|
ISS |
12 |
36,081,778 |
36,116,445 |
RGD:2311149 |
RGD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
|
IED |
5 |
66,283,165 |
66,296,171 |
RGD:2313414 |
RGD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
|
IEP |
5 |
66,283,165 |
66,296,171 |
RGD:2313414 |
RGD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
|
ISS |
5 |
66,283,165 |
66,296,171 |
RGD:2313434 |
RGD |
| G |
Alox12 |
arachidonate 12-lipoxygenase |
|
|
ISS |
10 |
57,080,603 |
57,092,874 |
RGD:2313877 |
RGD |
| G |
Angpt2 |
angiopoietin 2 |
|
|
ISS |
16 |
75,891,757 |
75,942,255 |
RGD:2313815 |
RGD |
| G |
Angptl3 |
angiopoietin-like 3 |
|
|
ISS |
5 |
119,479,669 |
119,484,358 |
RGD:2314234 |
RGD |
| G |
Ankrd23 |
ankyrin repeat domain 23 |
|
|
IEP |
9 |
35,472,715 |
35,479,314 |
RGD:2314859 |
RGD |
| G |
Aoc3 |
amine oxidase, copper containing 3 (vascular adhesion protein 1) |
|
|
ISS |
10 |
90,357,094 |
90,365,040 |
RGD:2313820 |
RGD |
| G |
Aoc3 |
amine oxidase, copper containing 3 (vascular adhesion protein 1) |
|
|
ISS |
10 |
90,357,094 |
90,365,040 |
RGD:2313822 |
RGD |
| G |
Aoc3 |
amine oxidase, copper containing 3 (vascular adhesion protein 1) |
|
|
IED |
10 |
90,357,094 |
90,365,040 |
RGD:2313823 |
RGD |
| G |
Apln |
apelin |
|
|
ISS |
X |
134,387,285 |
134,396,762 |
RGD:2313944 |
RGD |
| G |
Aplnr |
apelin receptor |
|
|
ISS |
3 |
68,365,637 |
68,369,282 |
RGD:2313945 |
RGD |
| G |
Apoa1 |
apolipoprotein A-I |
|
|
ISS |
|
|
|
RGD:2313961 |
RGD |
| G |
Apoa1 |
apolipoprotein A-I |
|
|
ISS |
|
|
|
RGD:7241576 |
RGD |
| G |
Apoa2 |
apolipoprotein A-II |
|
|
ISS |
13 |
87,114,734 |
87,116,372 |
RGD:2313955 |
RGD |
| G |
Apoa2 |
apolipoprotein A-II |
|
|
ISS |
13 |
87,114,734 |
87,116,372 |
RGD:2313961 |
RGD |
| G |
Apoa5 |
apolipoprotein A-V |
|
No_Association |
ISS |
8 |
49,253,538 |
49,255,777 |
RGD:2313319 |
RGD |
| G |
Apoa5 |
apolipoprotein A-V |
|
|
ISS |
8 |
49,253,538 |
49,255,777 |
RGD:2313318 |
RGD |
| G |
Apoa5 |
apolipoprotein A-V |
|
|
ISS |
8 |
49,253,538 |
49,255,777 |
RGD:2313321 |
RGD |
| G |
Apob |
apolipoprotein B |
|
|
ISS |
6 |
31,508,060 |
31,548,083 |
RGD:2313981 |
RGD |
| G |
Apoc1 |
apolipoprotein C-I |
|
|
ISS |
1 |
78,996,677 |
78,999,960 |
RGD:2313953 |
RGD |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
ISS |
1 |
78,979,034 |
78,984,002 |
RGD:2313966 |
RGD |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
ISS |
1 |
78,979,034 |
78,984,002 |
RGD:2313953 |
RGD |
| G |
Apod |
apolipoprotein D |
|
|
ISS |
|
|
|
RGD:2311178 |
RGD |
| G |
Apod |
apolipoprotein D |
|
|
ISS |
|
|
|
RGD:2311177 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
ISS |
1 |
79,003,634 |
79,006,387 |
RGD:2317556 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
IEA |
1 |
79,003,634 |
79,006,387 |
RGD:1331525 |
RGD |
| G |
Apoh |
apolipoprotein H (beta-2-glycoprotein I) |
|
|
ISS |
10 |
97,725,088 |
97,739,213 |
RGD:2313984 |
RGD |
| G |
Apom |
apolipoprotein M |
|
Susceptibility |
ISS |
20 |
3,754,604 |
3,757,204 |
RGD:2314248 |
RGD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
|
ISS |
2 |
190,333,978 |
190,391,015 |
RGD:2313995 |
RGD |
| G |
Arntl2 |
aryl hydrocarbon receptor nuclear translocator-like 2 |
|
|
ISS |
4 |
184,392,097 |
184,419,834 |
RGD:2314371 |
RGD |
| G |
Arx |
aristaless related homeobox |
|
Model |
IEP |
X |
80,631,375 |
80,643,989 |
RGD:1599258 |
RGD |
| G |
Asip |
agouti signaling protein |
|
|
ISS |
3 |
145,445,175 |
145,536,831 |
RGD:2313999 |
RGD |
| G |
Asl |
argininosuccinate lyase |
|
|
ISS |
12 |
27,702,882 |
27,720,230 |
RGD:2314010 |
RGD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
|
IEP |
12 |
35,266,600 |
35,316,237 |
RGD:6892953 |
RGD |
| G |
Avp |
arginine vasopressin |
|
|
IEP |
3 |
118,205,007 |
118,206,985 |
RGD:2301922 |
RGD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
|
ISS |
1 |
80,964,751 |
80,994,300 |
RGD:2325834 |
RGD |
| G |
B2m |
beta-2 microglobulin |
|
|
ISS |
3 |
108,927,919 |
108,932,718 |
RGD:2311236 |
RGD |
| G |
Bche |
butyrylcholinesterase |
|
Susceptibility |
ISS |
2 |
164,329,613 |
164,427,994 |
RGD:2306782 |
RGD |
| G |
Bche |
butyrylcholinesterase |
|
|
IEA |
2 |
164,329,613 |
164,427,994 |
RGD:1331525 |
RGD |
| G |
Bche |
butyrylcholinesterase |
|
|
ISS |
2 |
164,329,613 |
164,427,994 |
RGD:2306780 |
RGD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
|
ISS |
2 |
180,482,313 |
180,483,290 |
RGD:7207410 |
RGD |
| G |
Bscl2 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
|
No_Association |
IAGP |
1 |
211,509,675 |
211,518,963 |
RGD:1600600 |
RGD |
| G |
Btc |
betacellulin |
|
|
ISS |
14 |
18,194,470 |
18,235,228 |
RGD:2306967 |
RGD |
| G |
Btc |
betacellulin |
|
Susceptibility |
ISS |
14 |
18,194,470 |
18,235,228 |
RGD:2306973 |
RGD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
|
IEP |
1 |
172,686,168 |
172,691,061 |
RGD:2314035 |
RGD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
|
ISS |
1 |
172,686,168 |
172,691,061 |
RGD:2314032 |
RGD |
| G |
Calm1 |
calmodulin 1 |
|
|
IEP |
6 |
124,477,601 |
124,485,669 |
RGD:6892953 |
RGD |
| G |
Capn10 |
calpain 10 |
|
|
ISS |
|
|
|
RGD:1625049 |
RGD |
| G |
Capn10 |
calpain 10 |
|
|
ISS |
|
|
|
RGD:4107074 |
RGD |
| G |
Capn10 |
calpain 10 |
|
|
IAGP |
|
|
|
RGD:737693 |
RGD |
| G |
Capn10 |
calpain 10 |
|
|
ISS |
|
|
|
RGD:734686 |
RGD |
| G |
Capn10 |
calpain 10 |
|
|
IAGP |
|
|
|
RGD:1625063 |
RGD |
| G |
Cartpt |
CART prepropeptide |
|
|
IEP |
2 |
30,889,817 |
30,891,837 |
RGD:2313632 |
RGD |
| G |
Casp3 |
caspase 3 |
|
|
ISS |
16 |
48,944,226 |
48,962,420 |
RGD:2311446 |
RGD |
| G |
Casp8 |
caspase 8 |
|
|
ISS |
9 |
57,389,353 |
57,437,803 |
RGD:2311429 |
RGD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
|
ISS |
5 |
160,704,234 |
160,721,796 |
RGD:2311246 |
RGD |
| G |
Casq1 |
calsequestrin 1 (fast-twitch, skeletal muscle) |
|
No_Association |
ISS |
13 |
88,200,506 |
88,210,418 |
RGD:2314134 |
RGD |
| G |
Casq1 |
calsequestrin 1 (fast-twitch, skeletal muscle) |
|
|
ISS |
13 |
88,200,506 |
88,210,418 |
RGD:2314133 |
RGD |
| G |
Casq1 |
calsequestrin 1 (fast-twitch, skeletal muscle) |
|
|
ISS |
13 |
88,200,506 |
88,210,418 |
RGD:2314136 |
RGD |
| G |
Casq1 |
calsequestrin 1 (fast-twitch, skeletal muscle) |
|
|
ISS |
13 |
88,200,506 |
88,210,418 |
RGD:2314135 |
RGD |
| G |
Cckar |
cholecystokinin A receptor |
|
|
IAGP |
14 |
62,052,510 |
62,057,201 |
RGD:1625200 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IEP |
10 |
70,256,263 |
70,258,061 |
RGD:2301862 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:2307064 |
RGD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
|
ISS |
8 |
128,892,784 |
128,893,905 |
RGD:2313561 |
RGD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
|
ISS |
8 |
128,907,157 |
128,912,272 |
RGD:2307064 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
ISS |
4 |
13,471,878 |
13,525,620 |
RGD:2307218 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
ISS |
4 |
13,471,878 |
13,525,620 |
RGD:2307219 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
ISS |
4 |
13,471,878 |
13,525,620 |
RGD:2307212 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
Severity |
ISS |
4 |
13,471,878 |
13,525,620 |
RGD:2307213 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
IEP |
4 |
13,471,878 |
13,525,620 |
RGD:2307211 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
ISS |
4 |
13,471,878 |
13,525,620 |
RGD:6893499 |
RGD |
| G |
Cd38 |
CD38 molecule |
|
|
ISS |
14 |
72,320,479 |
72,360,329 |
RGD:2307233 |
RGD |
| G |
Cd38 |
CD38 molecule |
|
|
IEP |
14 |
72,320,479 |
72,360,329 |
RGD:2307234 |
RGD |
| G |
Cd38 |
CD38 molecule |
|
|
ISS |
14 |
72,320,479 |
72,360,329 |
RGD:2307232 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
ISS |
X |
141,925,019 |
141,937,183 |
RGD:2314214 |
RGD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
|
ISS |
|
|
|
RGD:2314611 |
RGD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
No_Association |
ISS |
|
|
|
RGD:2314610 |
RGD |
| G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
|
|
ISS |
17 |
41,208,037 |
41,259,863 |
RGD:7240710 |
OMIM |
| G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
|
|
ISS |
17 |
41,208,037 |
41,259,863 |
RGD:2313949 |
RGD |
| G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
|
|
ISS |
17 |
41,208,037 |
41,259,863 |
RGD:2313947 |
RGD |
| G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
|
|
ISS |
17 |
41,208,037 |
41,259,863 |
RGD:2313941 |
RGD |
| G |
Cel |
carboxyl ester lipase |
|
|
ISS |
3 |
7,541,127 |
7,549,245 |
RGD:2313964 |
RGD |
| G |
Chi3l1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
|
ISS |
13 |
47,139,658 |
47,147,591 |
RGD:4892628 |
RGD |
| G |
Clps |
colipase, pancreatic |
|
Susceptibility |
ISS |
20 |
6,802,428 |
6,804,608 |
RGD:2314627 |
RGD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
|
ISS |
5 |
50,427,173 |
50,445,471 |
RGD:2314632 |
RGD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
|
ISS |
2 |
105,086,278 |
105,135,367 |
RGD:2314681 |
RGD |
| G |
Cpb2 |
carboxypeptidase B2 (plasma) |
|
|
ISS |
15 |
56,104,920 |
56,154,321 |
RGD:2313645 |
RGD |
| G |
Cpe |
carboxypeptidase E |
|
Onset |
ISS |
|
|
|
RGD:1626183 |
RGD |
| G |
Cpe |
carboxypeptidase E |
|
No_Association |
ISS |
|
|
|
RGD:1626184 |
RGD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
|
IEP |
1 |
205,852,800 |
205,912,972 |
RGD:2311344 |
RGD |
| G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
|
IEP |
10 |
93,312,405 |
93,354,229 |
RGD:5507823 |
RGD |
| G |
Cst3 |
cystatin C |
|
|
ISS |
3 |
137,650,903 |
137,654,776 |
RGD:2314295 |
RGD |
| G |
Ctgf |
connective tissue growth factor |
|
|
IEP |
1 |
21,327,099 |
21,330,215 |
RGD:2314357 |
RGD |
| G |
Ctsb |
cathepsin B |
|
|
ISS |
15 |
42,402,829 |
42,423,701 |
RGD:2315527 |
RGD |
| G |
Ctsl1 |
cathepsin L1 |
|
Susceptibility |
ISS |
17 |
6,288,013 |
6,294,174 |
RGD:2315625 |
RGD |
| G |
Ctsl1 |
cathepsin L1 |
|
|
ISS |
17 |
6,288,013 |
6,294,174 |
RGD:2315622 |
RGD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
|
ISS |
14 |
17,265,986 |
17,268,183 |
RGD:2311356 |
RGD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
|
ISS |
4 |
153,503,576 |
153,516,423 |
RGD:2306553 |
RGD |
| G |
Cyb5r4 |
cytochrome b5 reductase 4 |
|
|
ISS |
8 |
92,278,453 |
92,343,490 |
RGD:2315647 |
RGD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
|
IEP |
8 |
61,793,976 |
61,805,308 |
RGD:4889107 |
RGD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
|
ISS |
7 |
113,043,365 |
113,049,779 |
RGD:2307288 |
RGD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
|
ISS |
8 |
61,462,207 |
61,468,237 |
RGD:2307073 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
|
ISS |
1 |
200,918,521 |
200,928,919 |
RGD:2313686 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
|
IEP |
1 |
200,918,521 |
200,928,919 |
RGD:2313688 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
|
ISS |
1 |
200,918,521 |
200,928,919 |
RGD:2313687 |
RGD |
| G |
Dcn |
decorin |
|
|
ISS |
7 |
35,004,234 |
35,045,191 |
RGD:2311410 |
RGD |
| G |
Defb1 |
defensin beta 1 |
|
|
IEP |
16 |
74,980,054 |
74,995,445 |
RGD:4892271 |
RGD |
| G |
Dio2 |
deiodinase, iodothyronine, type II |
|
No_Association |
ISS |
6 |
114,307,758 |
114,317,563 |
RGD:1626439 |
RGD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
|
ISS |
3 |
44,279,255 |
44,360,283 |
RGD:2313700 |
RGD |
| G |
Drd2 |
dopamine receptor D2 |
|
|
ISS |
8 |
52,641,160 |
52,707,749 |
RGD:2311601 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
IEP |
17 |
28,303,886 |
28,309,775 |
RGD:2313280 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
ISS |
17 |
28,303,886 |
28,309,775 |
RGD:2313278 |
RGD |
| G |
Ednra |
endothelin receptor type A |
|
|
IEP |
19 |
32,042,366 |
32,108,153 |
RGD:2313280 |
RGD |
| G |
Ednrb |
endothelin receptor type B |
|
|
IED |
15 |
87,893,141 |
87,898,700 |
RGD:2313280 |
RGD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
|
ISS |
1 |
21,223,678 |
21,287,411 |
RGD:1601042 |
RGD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
|
ISS |
1 |
21,223,678 |
21,287,411 |
RGD:7240710 |
OMIM |
| G |
Epo |
erythropoietin |
|
|
ISS |
12 |
19,551,768 |
19,555,208 |
RGD:2313842 |
RGD |
| G |
Epo |
erythropoietin |
|
|
ISS |
12 |
19,551,768 |
19,555,208 |
RGD:2313840 |
RGD |
| G |
Esr1 |
estrogen receptor 1 |
|
|
ISS |
1 |
35,523,680 |
35,759,891 |
RGD:2314012 |
RGD |
| G |
Esr1 |
estrogen receptor 1 |
|
|
ISS |
1 |
35,523,680 |
35,759,891 |
RGD:2314003 |
RGD |
| G |
Esrra |
estrogen related receptor, alpha |
|
No_Association |
ISS |
1 |
209,587,681 |
209,597,677 |
RGD:1625637 |
RGD |
| G |
Ets1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
|
ISS |
8 |
32,481,694 |
32,545,237 |
RGD:2313847 |
RGD |
| G |
Ets1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
|
ISS |
8 |
32,481,694 |
32,545,237 |
RGD:2313847 |
RGD |
| G |
F12 |
coagulation factor XII (Hageman factor) |
|
|
ISS |
17 |
15,251,611 |
15,259,583 |
RGD:2312416 |
RGD |
| G |
F2 |
coagulation factor II |
|
|
ISS |
3 |
76,005,318 |
76,018,603 |
RGD:2313851 |
RGD |
| G |
F2 |
coagulation factor II |
|
|
ISS |
3 |
76,005,318 |
76,018,603 |
RGD:2313852 |
RGD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
|
ISS |
2 |
218,371,050 |
218,382,645 |
RGD:2312381 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
Susceptibility |
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312388 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312380 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312383 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312381 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312382 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
IED |
16 |
81,348,678 |
81,358,991 |
RGD:2312394 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
No_Association |
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312386 |
RGD |
| G |
F8 |
coagulation factor VIII, procoagulant component |
|
|
ISS |
18 |
121,134 |
162,008 |
RGD:2312416 |
RGD |
| G |
F9 |
coagulation factor IX |
|
|
ISS |
X |
145,527,978 |
145,575,966 |
RGD:2312416 |
RGD |
| G |
Fabp2 |
fatty acid binding protein 2, intestinal |
|
|
ISS |
2 |
219,591,502 |
219,605,097 |
RGD:1300313 |
RGD |
| G |
Fabp2 |
fatty acid binding protein 2, intestinal |
|
No_Association |
ISS |
2 |
219,591,502 |
219,605,097 |
RGD:1626401 |
RGD |
| G |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
|
|
ISS |
5 |
149,340,525 |
149,347,268 |
RGD:1578461 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
13 |
77,472,950 |
77,480,210 |
RGD:2315750 |
RGD |
| G |
Ffar1 |
free fatty acid receptor 1 |
|
|
ISS |
1 |
85,917,624 |
85,918,528 |
RGD:2316010 |
RGD |
| G |
Ffar1 |
free fatty acid receptor 1 |
|
|
ISS |
1 |
85,917,624 |
85,918,528 |
RGD:2315761 |
RGD |
| G |
Fga |
fibrinogen alpha chain |
|
|
ISS |
2 |
174,737,640 |
174,753,598 |
RGD:2312416 |
RGD |
| G |
Fgb |
fibrinogen beta chain |
|
|
ISS |
2 |
174,768,193 |
174,775,102 |
RGD:2312416 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2315844 |
RGD |
| G |
Fgg |
fibrinogen gamma chain |
|
|
ISS |
2 |
174,727,312 |
174,734,594 |
RGD:2312416 |
RGD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
|
ISS |
12 |
7,858,092 |
8,035,966 |
RGD:2313719 |
RGD |
| G |
Foxa2 |
forkhead box A2 |
|
|
ISS |
3 |
136,739,009 |
136,743,204 |
RGD:2313242 |
RGD |
| G |
Foxa2 |
forkhead box A2 |
|
|
ISS |
3 |
136,739,009 |
136,743,204 |
RGD:2313245 |
RGD |
| G |
Foxa2 |
forkhead box A2 |
|
No_Association |
ISS |
3 |
136,739,009 |
136,743,204 |
RGD:2313246 |
RGD |
| G |
Foxc2 |
forkhead box C2 |
|
|
ISS |
|
|
|
RGD:1601217 |
RGD |
| G |
Foxc2 |
forkhead box C2 |
|
No_Association |
ISS |
|
|
|
RGD:1601220 |
RGD |
| G |
Foxo1 |
forkhead box O1 |
|
|
ISS |
2 |
141,127,345 |
141,203,446 |
RGD:704404 |
RGD |
| G |
Fuca1 |
fucosidase, alpha-L- 1, tissue |
|
|
ISS |
5 |
154,703,722 |
154,720,971 |
RGD:2315931 |
RGD |
| G |
Fxn |
frataxin |
|
No_Association |
ISS |
1 |
227,647,092 |
227,671,081 |
RGD:2307051 |
RGD |
| G |
Fxn |
frataxin |
|
|
ISS |
1 |
227,647,092 |
227,671,081 |
RGD:2307050 |
RGD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
|
ISS |
10 |
90,393,531 |
90,403,485 |
RGD:728661 |
RGD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
|
ISS |
10 |
90,393,531 |
90,403,485 |
RGD:2315966 |
RGD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
|
IED |
10 |
90,393,531 |
90,403,485 |
RGD:2315959 |
RGD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
|
ISS |
X |
160,186,450 |
160,192,316 |
RGD:2307349 |
RGD |
| G |
Gal |
galanin/GMAP prepropeptide |
|
|
ISS |
1 |
205,936,352 |
205,941,215 |
RGD:2313738 |
RGD |
| G |
Gcgr |
glucagon receptor |
|
|
ISS |
10 |
109,921,411 |
109,929,577 |
RGD:1625208 |
RGD |
| G |
Gcgr |
glucagon receptor |
|
|
ISS |
10 |
109,921,411 |
109,929,577 |
RGD:704404 |
RGD |
| G |
Gcgr |
glucagon receptor |
|
|
ISS |
10 |
109,921,411 |
109,929,577 |
RGD:7240710 |
OMIM |
| G |
Gck |
glucokinase |
|
No_Association |
ISS |
14 |
86,572,518 |
86,587,723 |
RGD:2301883 |
RGD |
| G |
Gck |
glucokinase |
|
|
ISS |
14 |
86,572,518 |
86,587,723 |
RGD:1601292 |
RGD |
| G |
Gck |
glucokinase |
|
|
IED |
14 |
86,572,518 |
86,587,723 |
RGD:1582633 |
RGD |
| G |
Gck |
glucokinase |
|
|
ISS |
14 |
86,572,518 |
86,587,723 |
RGD:2301889 |
RGD |
| G |
Gck |
glucokinase |
|
No_Association |
ISS |
14 |
86,572,518 |
86,587,723 |
RGD:2301887 |
RGD |
| G |
Gck |
glucokinase |
|
|
ISS |
14 |
86,572,518 |
86,587,723 |
RGD:704404 |
RGD |
| G |
Gck |
glucokinase |
|
|
ISS |
14 |
86,572,518 |
86,587,723 |
RGD:7240710 |
OMIM |
| G |
Gckr |
glucokinase (hexokinase 4) regulator |
|
|
ISS |
|
|
|
RGD:2315986 |
RGD |
| G |
Gckr |
glucokinase (hexokinase 4) regulator |
|
|
ISS |
|
|
|
RGD:2315983 |
RGD |
| G |
Gckr |
glucokinase (hexokinase 4) regulator |
|
|
ISS |
|
|
|
RGD:2315985 |
RGD |
| G |
Gckr |
glucokinase (hexokinase 4) regulator |
|
|
ISS |
|
|
|
RGD:7242280 |
RGD |
| G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
|
|
ISS |
4 |
121,204,274 |
121,250,160 |
RGD:2313352 |
RGD |
| G |
Gfpt2 |
glutamine-fructose-6-phosphate transaminase 2 |
|
Susceptibility |
ISS |
10 |
35,290,139 |
35,336,286 |
RGD:2307362 |
RGD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
|
ISS |
|
|
|
RGD:2315593 |
RGD |
| G |
Ghr |
growth hormone receptor |
|
|
ISS |
2 |
52,496,517 |
52,658,066 |
RGD:2307363 |
RGD |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
Susceptibility |
ISS |
4 |
149,622,566 |
149,628,111 |
RGD:2313749 |
RGD |
| G |
Gip |
gastric inhibitory polypeptide |
|
|
ISS |
10 |
84,732,705 |
84,740,801 |
RGD:2312591 |
RGD |
| G |
Gip |
gastric inhibitory polypeptide |
|
|
ISS |
10 |
84,732,705 |
84,740,801 |
RGD:2312587 |
RGD |
| G |
Gip |
gastric inhibitory polypeptide |
|
|
IED |
10 |
84,732,705 |
84,740,801 |
RGD:2312529 |
RGD |
| G |
Gipr |
gastric inhibitory polypeptide receptor |
|
|
ISS |
1 |
78,515,051 |
78,526,160 |
RGD:2312454 |
RGD |
| G |
Gipr |
gastric inhibitory polypeptide receptor |
|
|
IED |
1 |
78,515,051 |
78,526,160 |
RGD:68929 |
RGD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
|
IEP |
20 |
35,409,815 |
35,422,262 |
RGD:7207393 |
RGD |
| G |
Glo1 |
glyoxalase 1 |
|
|
ISS |
20 |
8,900,984 |
8,919,001 |
RGD:7242567 |
RGD |
| G |
Gnb3 |
guanine nucleotide binding protein (G protein), beta polypeptide 3 |
|
|
ISS |
4 |
160,957,524 |
160,963,226 |
RGD:2313204 |
RGD |
| G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2, mitochondrial |
|
|
ISS |
3 |
38,980,634 |
39,114,492 |
RGD:704404 |
RGD |
| G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2, mitochondrial |
|
|
ISS |
3 |
38,980,634 |
39,114,492 |
RGD:7240710 |
OMIM |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
|
ISS |
10 |
40,311,094 |
40,319,382 |
RGD:2312632 |
RGD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
Not |
ISS |
2 |
203,575,444 |
203,580,821 |
RGD:2306628 |
RGD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
Susceptibility |
ISS |
2 |
203,575,444 |
203,580,821 |
RGD:2306627 |
RGD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
Susceptibility |
ISS |
2 |
203,575,444 |
203,580,821 |
RGD:5490963 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
Susceptibility |
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:5490963 |
RGD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
Susceptibility |
ISS |
20 |
13,604,355 |
13,621,456 |
RGD:2306627 |
RGD |
| G |
Hgf |
hepatocyte growth factor |
|
|
ISS |
4 |
14,864,357 |
14,932,513 |
RGD:7240710 |
OMIM |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
|
IEP |
6 |
96,419,024 |
96,463,891 |
RGD:625730 |
RGD |
| G |
Hk2 |
hexokinase 2 |
|
|
ISS |
4 |
116,925,725 |
116,975,211 |
RGD:2313229 |
RGD |
| G |
Hk2 |
hexokinase 2 |
|
|
ISS |
4 |
116,925,725 |
116,975,211 |
RGD:2313227 |
RGD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
|
ISS |
2 |
27,127,504 |
27,149,580 |
RGD:2313753 |
RGD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
|
IPM |
2 |
27,127,504 |
27,149,580 |
RGD:2313759 |
RGD |
| G |
Hnf1a |
HNF1 homeobox A |
|
|
ISS |
12 |
42,919,574 |
42,945,670 |
RGD:2301828 |
RGD |
| G |
Hnf1a |
HNF1 homeobox A |
|
Susceptibility |
ISS |
12 |
42,919,574 |
42,945,670 |
RGD:2301863 |
RGD |
| G |
Hnf1a |
HNF1 homeobox A |
|
Susceptibility |
ISS |
12 |
42,919,574 |
42,945,670 |
RGD:1601479 |
RGD |
| G |
Hnf1a |
HNF1 homeobox A |
|
Onset |
ISS |
12 |
42,919,574 |
42,945,670 |
RGD:2301827 |
RGD |
| G |
Hnf1a |
HNF1 homeobox A |
|
|
ISS |
12 |
42,919,574 |
42,945,670 |
RGD:7240710 |
OMIM |
| G |
Hnf1b |
HNF1 homeobox B |
|
Susceptibility |
ISS |
10 |
72,081,091 |
72,187,014 |
RGD:1601484 |
RGD |
| G |
Hnf1b |
HNF1 homeobox B |
|
|
ISS |
10 |
72,081,091 |
72,187,014 |
RGD:2312748 |
RGD |
| G |
Hnf1b |
HNF1 homeobox B |
|
No_Association |
ISS |
10 |
72,081,091 |
72,187,014 |
RGD:2312750 |
RGD |
| G |
Hnf1b |
HNF1 homeobox B |
|
|
ISS |
10 |
72,081,091 |
72,187,014 |
RGD:7240710 |
OMIM |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
Susceptibility |
ISS |
3 |
154,459,863 |
154,482,825 |
RGD:2301836 |
RGD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
Susceptibility |
ISS |
3 |
154,459,863 |
154,482,825 |
RGD:2301839 |
RGD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
|
ISS |
3 |
154,459,863 |
154,482,825 |
RGD:1601637 |
RGD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
Susceptibility |
ISS |
3 |
154,459,863 |
154,482,825 |
RGD:2301863 |
RGD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
|
ISS |
3 |
154,459,863 |
154,482,825 |
RGD:7240710 |
OMIM |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
|
IEP |
13 |
109,063,491 |
109,089,468 |
RGD:1625074 |
RGD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
|
ISS |
19 |
35,336,342 |
35,341,585 |
RGD:2308922 |
RGD |
| G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
|
|
IEP |
17 |
6,554,164 |
6,585,525 |
RGD:4889107 |
RGD |
| G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
|
IEP |
2 |
193,500,916 |
193,507,633 |
RGD:4889107 |
RGD |
| G |
Hspa1b |
heat shock protein 1B |
|
|
ISS |
20 |
3,955,274 |
3,957,748 |
RGD:1626646 |
RGD |
| G |
Hspa4 |
heat shock protein 4 |
|
|
ISS |
10 |
38,705,629 |
38,749,058 |
RGD:6218966 |
RGD |
| G |
Iapp |
islet amyloid polypeptide |
|
|
ISS |
4 |
179,855,956 |
179,860,871 |
RGD:2313359 |
RGD |
| G |
Iapp |
islet amyloid polypeptide |
|
|
ISS |
4 |
179,855,956 |
179,860,871 |
RGD:728955 |
RGD |
| G |
Iapp |
islet amyloid polypeptide |
|
|
ISS |
4 |
179,855,956 |
179,860,871 |
RGD:2311446 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
IEP |
8 |
20,040,177 |
20,051,939 |
RGD:4145422 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:2312766 |
RGD |
| G |
Ide |
insulin degrading enzyme |
|
No_Association |
ISS |
1 |
241,547,869 |
241,646,052 |
RGD:1626698 |
RGD |
| G |
Ide |
insulin degrading enzyme |
|
|
ISS |
1 |
241,547,869 |
241,646,052 |
RGD:737718 |
RGD |
| G |
Ide |
insulin degrading enzyme |
|
|
ISS |
1 |
241,547,869 |
241,646,052 |
RGD:1626697 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
ISS |
7 |
57,621,756 |
57,625,792 |
RGD:2311491 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
IEP |
7 |
24,531,669 |
24,605,742 |
RGD:2306690 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
ISS |
7 |
24,531,669 |
24,605,742 |
RGD:2313767 |
RGD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
IEP |
1 |
122,704,976 |
122,990,007 |
RGD:2306690 |
RGD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
IEP |
1 |
122,704,976 |
122,990,007 |
RGD:2311504 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
IEP |
1 |
202,906,624 |
202,915,231 |
RGD:2311504 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
ISS |
1 |
202,906,624 |
202,915,231 |
RGD:5510004 |
RGD |
| G |
Igf2bp2 |
insulin-like growth factor 2 mRNA binding protein 2 |
|
|
ISS |
11 |
81,115,320 |
81,216,170 |
RGD:7240710 |
OMIM |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
Susceptibility |
ISS |
1 |
42,253,273 |
42,341,646 |
RGD:2311514 |
RGD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
|
ISS |
14 |
87,959,153 |
87,967,085 |
RGD:2313767 |
RGD |
| G |
Il10 |
interleukin 10 |
|
Susceptibility |
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:2308943 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
Susceptibility |
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:7175255 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
Disease_progression |
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:7175255 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
No_Association |
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:6907412 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
Susceptibility |
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:6907409 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307270 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
IEP |
4 |
456,799 |
461,376 |
RGD:2307269 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307266 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:7240710 |
OMIM |
| G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
|
|
ISS |
1 |
159,278,131 |
159,292,740 |
RGD:1626127 |
RGD |
| G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
|
|
ISS |
1 |
159,278,131 |
159,292,740 |
RGD:633161 |
RGD |
| G |
Ins1 |
insulin 1 |
|
|
ISS |
1 |
258,001,134 |
258,001,688 |
RGD:1625120 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:1625120 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2311112 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2311111 |
RGD |
| G |
Insr |
insulin receptor |
|
|
IEP |
12 |
2,934,967 |
3,087,691 |
RGD:2290475 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISS |
12 |
2,934,967 |
3,087,691 |
RGD:2307342 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISS |
9 |
81,585,251 |
81,638,071 |
RGD:1624975 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
No_Association |
ISS |
9 |
81,585,251 |
81,638,071 |
RGD:6482863 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IED |
9 |
81,585,251 |
81,638,071 |
RGD:6483016 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IED |
9 |
81,585,251 |
81,638,071 |
RGD:6483015 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISS |
9 |
81,585,251 |
81,638,071 |
RGD:7207057 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISS |
9 |
81,585,251 |
81,638,071 |
RGD:7240710 |
OMIM |
| G |
Irs2 |
insulin receptor substrate 2 |
|
|
ISS |
16 |
83,379,987 |
83,404,220 |
RGD:1625023 |
RGD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
|
ISS |
16 |
83,379,987 |
83,404,220 |
RGD:7240710 |
OMIM |
| G |
Isl1 |
ISL LIM homeobox 1 |
|
|
ISS |
2 |
48,050,124 |
48,060,394 |
RGD:2311117 |
RGD |
| G |
Itga2 |
integrin, alpha 2 |
|
|
ISS |
2 |
46,967,681 |
47,080,909 |
RGD:2307425 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:2313610 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:2311533 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:2311534 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:2313628 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:7240710 |
OMIM |
| G |
Kdr |
kinase insert domain receptor |
|
|
ISS |
|
|
|
RGD:5684411 |
RGD |
| G |
Klf11 |
Kruppel-like factor 11 |
|
|
ISS |
6 |
42,296,221 |
42,307,925 |
RGD:2311540 |
RGD |
| G |
Lep |
leptin |
|
|
IPM |
4 |
55,943,837 |
55,945,938 |
RGD:2311130 |
RGD |
| G |
Lepr |
leptin receptor |
|
Susceptibility |
ISS |
5 |
122,320,075 |
122,503,449 |
RGD:2311144 |
RGD |
| G |
Lepr |
leptin receptor |
|
|
ISS |
5 |
122,320,075 |
122,503,449 |
RGD:2311141 |
RGD |
| G |
Lipc |
lipase, hepatic |
|
|
ISS |
8 |
75,323,442 |
75,450,353 |
RGD:2308826 |
RGD |
| G |
Lipc |
lipase, hepatic |
|
Susceptibility |
ISS |
8 |
75,323,442 |
75,450,353 |
RGD:2308830 |
RGD |
| G |
Lipc |
lipase, hepatic |
|
|
ISS |
8 |
75,323,442 |
75,450,353 |
RGD:7240710 |
OMIM |
| G |
Lipe |
lipase, hormone sensitive |
|
|
ISS |
1 |
80,663,791 |
80,682,480 |
RGD:2313584 |
RGD |
| G |
Liph |
lipase, member H |
|
|
ISS |
|
|
|
RGD:7240710 |
OMIM |
| G |
Lmna |
lamin A/C |
|
|
ISS |
2 |
180,595,724 |
180,616,354 |
RGD:1624985 |
RGD |
| G |
Lmna |
lamin A/C |
|
No_Association |
ISS |
2 |
180,595,724 |
180,616,354 |
RGD:1624984 |
RGD |
| G |
Lnpep |
leucyl/cystinyl aminopeptidase |
|
|
ISS |
1 |
56,063,361 |
56,151,257 |
RGD:2311542 |
RGD |
| G |
Lnpep |
leucyl/cystinyl aminopeptidase |
|
|
IED |
1 |
56,063,361 |
56,151,257 |
RGD:2306436 |
RGD |
| G |
Lpl |
lipoprotein lipase |
|
|
ISS |
16 |
22,533,105 |
22,556,905 |
RGD:2313298 |
RGD |
| G |
Lpl |
lipoprotein lipase |
|
|
ISS |
16 |
22,533,105 |
22,556,905 |
RGD:1580537 |
RGD |
| G |
Lpl |
lipoprotein lipase |
|
|
ISS |
16 |
22,533,105 |
22,556,905 |
RGD:2313304 |
RGD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
Onset |
ISS |
20 |
3,657,842 |
3,659,848 |
RGD:1625033 |
RGD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
No_Association |
ISS |
20 |
3,657,842 |
3,659,848 |
RGD:2313261 |
RGD |
| G |
Mapk8ip1 |
mitogen-activated protein kinase 8 interacting protein 1 |
|
|
ISS |
3 |
76,781,504 |
76,790,661 |
RGD:7240710 |
OMIM |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
IEP |
20 |
13,191,986 |
13,192,851 |
RGD:1641984 |
RGD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
|
IEP |
1 |
195,310,027 |
195,336,224 |
RGD:2317709 |
RGD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
|
ISS |
8 |
4,333,773 |
4,354,284 |
RGD:2312464 |
RGD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
|
IEP |
8 |
4,333,773 |
4,354,284 |
RGD:7207379 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
|
ISS |
19 |
15,246,036 |
15,275,061 |
RGD:7207195 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:7207195 |
RGD |
| G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
|
IEP |
MT |
7,006 |
7,689 |
RGD:2300410 |
RGD |
| G |
Mt-cyb |
mitochondrially encoded cytochrome b |
|
|
IEP |
MT |
14,136 |
15,278 |
RGD:2298962 |
RGD |
| G |
Mt-nd1 |
mitochondrially encoded NADH dehydrogenase 1 |
|
|
ISS |
MT |
2,740 |
3,694 |
RGD:2311583 |
RGD |
| G |
Mt-nd1 |
mitochondrially encoded NADH dehydrogenase 1 |
|
|
IEP |
MT |
2,740 |
3,694 |
RGD:2300410 |
RGD |
| G |
Mt-nd1 |
mitochondrially encoded NADH dehydrogenase 1 |
|
|
ISS |
MT |
2,740 |
3,694 |
RGD:2311592 |
RGD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
Susceptibility |
ISS |
5 |
165,112,850 |
165,126,885 |
RGD:6893657 |
RGD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
Susceptibility |
ISS |
5 |
165,112,850 |
165,126,885 |
RGD:6893476 |
RGD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
No_Association |
ISS |
5 |
165,112,850 |
165,126,885 |
RGD:6893653 |
RGD |
| G |
Mtnr1b |
melatonin receptor 1B |
|
|
ISS |
8 |
12,625,154 |
12,639,670 |
RGD:7240710 |
OMIM |
| G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
|
IEP |
17 |
68,782,708 |
68,867,101 |
RGD:7207079 |
RGD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
|
ISS |
6 |
51,129,160 |
51,166,514 |
RGD:2311099 |
RGD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
|
ISS |
3 |
62,224,633 |
62,227,936 |
RGD:2313488 |
RGD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
Onset |
ISS |
3 |
62,224,633 |
62,227,936 |
RGD:2313482 |
RGD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
|
ISS |
3 |
62,224,633 |
62,227,936 |
RGD:2313480 |
RGD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
|
ISS |
3 |
62,224,633 |
62,227,936 |
RGD:2313489 |
RGD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
No_Association |
ISS |
3 |
62,224,633 |
62,227,936 |
RGD:2313486 |
RGD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
|
ISS |
3 |
62,224,633 |
62,227,936 |
RGD:2313478 |
RGD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
|
ISS |
3 |
62,224,633 |
62,227,936 |
RGD:7240710 |
OMIM |
| G |
Neurog3 |
neurogenin 3 |
|
|
ISS |
20 |
29,522,778 |
29,524,261 |
RGD:2313775 |
RGD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
|
IEP |
12 |
39,812,500 |
39,869,484 |
RGD:1581689 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:5508747 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
Susceptibility |
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:2312484 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:2313220 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IEP |
4 |
6,158,847 |
6,179,441 |
RGD:2292097 |
RGD |
| G |
Nppa |
natriuretic peptide A |
|
|
ISS |
5 |
165,074,518 |
165,075,827 |
RGD:2313586 |
RGD |
| G |
Nppb |
natriuretic peptide B |
|
|
ISS |
5 |
165,062,348 |
165,063,650 |
RGD:5685645 |
RGD |
| G |
Nppb |
natriuretic peptide B |
|
|
IEP |
5 |
165,062,348 |
165,063,650 |
RGD:2293330 |
RGD |
| G |
Npy |
neuropeptide Y |
|
|
IAGP |
4 |
78,038,013 |
78,045,187 |
RGD:1580183 |
RGD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
|
ISS |
5 |
151,524,685 |
151,528,000 |
RGD:2311604 |
RGD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
|
ISS |
1 |
95,027,197 |
95,032,516 |
RGD:6482187 |
RGD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
|
IED |
18 |
32,371,496 |
32,459,145 |
RGD:4892117 |
RGD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
|
ISS |
4 |
149,209,745 |
149,219,081 |
RGD:2317133 |
RGD |
| G |
Oxct1 |
3-oxoacid CoA transferase 1 |
|
|
IEP |
2 |
53,189,358 |
53,217,848 |
RGD:2326185 |
RGD |
| G |
P2ry12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
|
ISS |
2 |
148,611,035 |
148,613,985 |
RGD:6480536 |
RGD |
| G |
Pappa |
pregnancy-associated plasma protein A |
|
|
ISS |
5 |
81,826,649 |
82,096,446 |
RGD:2313776 |
RGD |
| G |
Pax4 |
paired box 4 |
|
|
ISS |
4 |
55,313,500 |
55,318,995 |
RGD:2311632 |
RGD |
| G |
Pax4 |
paired box 4 |
|
Onset |
IPM |
4 |
55,313,500 |
55,318,995 |
RGD:2311635 |
RGD |
| G |
Pax4 |
paired box 4 |
|
|
ISS |
4 |
55,313,500 |
55,318,995 |
RGD:7240710 |
OMIM |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
|
IED |
3 |
164,012,410 |
164,018,359 |
RGD:2311643 |
RGD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
|
ISS |
3 |
164,012,410 |
164,018,359 |
RGD:2311640 |
RGD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
|
ISS |
3 |
164,012,410 |
164,018,359 |
RGD:2311639 |
RGD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
No_Association |
ISS |
3 |
164,012,410 |
164,018,359 |
RGD:1601239 |
RGD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
No_Association |
ISS |
3 |
164,012,410 |
164,018,359 |
RGD:1601241 |
RGD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
No_Association |
ISS |
2 |
1,923,309 |
1,970,238 |
RGD:2308935 |
RGD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
|
IAGP |
2 |
1,923,309 |
1,970,238 |
RGD:2308898 |
RGD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
|
IAGP |
2 |
1,923,309 |
1,970,238 |
RGD:2298715 |
RGD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
|
ISS |
2 |
1,923,309 |
1,970,238 |
RGD:2308932 |
RGD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
|
ISS |
2 |
1,923,309 |
1,970,238 |
RGD:2308930 |
RGD |
| G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
|
ISS |
3 |
131,925,648 |
132,256,178 |
RGD:2308936 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
ISS |
|
|
|
RGD:2311308 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
ISS |
|
|
|
RGD:2311221 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
ISS |
|
|
|
RGD:2311306 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
ISS |
|
|
|
RGD:2311217 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
ISS |
|
|
|
RGD:2311307 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
ISS |
|
|
|
RGD:2311305 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
IED |
|
|
|
RGD:2311214 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
IEP |
|
|
|
RGD:2311219 |
RGD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
|
ISS |
10 |
96,056,220 |
96,057,232 |
RGD:6771358 |
RGD |
| G |
Pik3c2a |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha |
|
|
ISS |
1 |
174,430,831 |
174,537,706 |
RGD:7243008 |
RGD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
|
IEP |
2 |
32,602,673 |
32,675,350 |
RGD:4108490 |
RGD |
| G |
Pla2g7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
|
|
ISS |
9 |
13,057,988 |
13,100,289 |
RGD:6482782 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
IEP |
16 |
73,711,323 |
73,736,328 |
RGD:2311675 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
ISS |
16 |
73,711,323 |
73,736,328 |
RGD:2311672 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
ISS |
16 |
73,711,323 |
73,736,328 |
RGD:2311665 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
ISS |
16 |
73,711,323 |
73,736,328 |
RGD:2311670 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
ISS |
16 |
73,711,323 |
73,736,328 |
RGD:2311673 |
RGD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
Onset |
ISS |
1 |
79,708,646 |
79,712,881 |
RGD:6483792 |
RGD |
| G |
Pon1 |
paraoxonase 1 |
|
|
ISS |
4 |
29,936,314 |
29,964,821 |
RGD:2313270 |
RGD |
| G |
Pon1 |
paraoxonase 1 |
|
|
ISS |
4 |
29,936,314 |
29,964,821 |
RGD:2307252 |
RGD |
| G |
Pon1 |
paraoxonase 1 |
|
|
ISS |
4 |
29,936,314 |
29,964,821 |
RGD:2313269 |
RGD |
| G |
Pon2 |
paraoxonase 2 |
|
|
ISS |
4 |
30,033,229 |
30,068,643 |
RGD:2313490 |
RGD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
|
ISS |
20 |
6,479,108 |
6,544,255 |
RGD:1625186 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:2301861 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:2301846 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
Susceptibility |
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:2301851 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:1580657 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:7240710 |
OMIM |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
No_Association |
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7242043 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
Susceptibility |
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7242032 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7242009 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:2311391 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
Treatment |
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7241851 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7241849 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
Treatment |
IED |
14 |
64,278,115 |
64,370,912 |
RGD:7242067 |
RGD |
| G |
Ppargc1b |
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
|
No_Association |
ISS |
18 |
57,277,749 |
57,301,024 |
RGD:1642500 |
RGD |
| G |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
|
|
ISS |
4 |
40,195,325 |
40,235,913 |
RGD:2311532 |
RGD |
| G |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
|
|
ISS |
4 |
40,195,325 |
40,235,913 |
RGD:2311531 |
RGD |
| G |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
|
|
ISS |
4 |
40,195,325 |
40,235,913 |
RGD:1601446 |
RGD |
| G |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
|
|
ISS |
4 |
40,195,325 |
40,235,913 |
RGD:2311560 |
RGD |
| G |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
|
No_Association |
ISS |
4 |
40,195,325 |
40,235,913 |
RGD:2311552 |
RGD |
| G |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
|
No_Association |
ISS |
4 |
40,195,325 |
40,235,913 |
RGD:2311515 |
RGD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
|
IPM |
2 |
54,327,821 |
54,360,462 |
RGD:2316808 |
RGD |
| G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
|
Susceptibility |
ISS |
5 |
126,007,672 |
126,074,012 |
RGD:1625266 |
RGD |
| G |
Ptgds |
prostaglandin D2 synthase (brain) |
|
|
IEP |
3 |
3,632,683 |
3,635,617 |
RGD:1642580 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IEP |
13 |
64,427,288 |
64,432,978 |
RGD:2300222 |
RGD |
| G |
Pth |
parathyroid hormone |
|
|
ISS |
1 |
171,240,596 |
171,243,528 |
RGD:7242744 |
RGD |
| G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
|
ISS |
3 |
159,070,473 |
159,116,792 |
RGD:7240710 |
OMIM |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
|
IEP |
1 |
242,443,795 |
242,450,997 |
RGD:2311652 |
RGD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
|
ISS |
1 |
242,443,795 |
242,450,997 |
RGD:2311651 |
RGD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
Susceptibility |
ISS |
1 |
242,443,795 |
242,450,997 |
RGD:1601615 |
RGD |
| G |
Retn |
resistin |
|
|
ISS |
12 |
2,499,630 |
2,501,370 |
RGD:1624968 |
RGD |
| G |
Retn |
resistin |
|
|
ISS |
12 |
2,499,630 |
2,501,370 |
RGD:2313494 |
RGD |
| G |
Retn |
resistin |
|
|
ISS |
12 |
2,499,630 |
2,501,370 |
RGD:2313498 |
RGD |
| G |
Retn |
resistin |
|
|
ISS |
12 |
2,499,630 |
2,501,370 |
RGD:2313497 |
RGD |
| G |
Retn |
resistin |
|
No_Association |
ISS |
12 |
2,499,630 |
2,501,370 |
RGD:2313495 |
RGD |
| G |
Retn |
resistin |
|
|
ISS |
12 |
2,499,630 |
2,501,370 |
RGD:7207163 |
RGD |
| G |
Retn |
resistin |
|
|
ISS |
12 |
2,499,630 |
2,501,370 |
RGD:7240710 |
OMIM |
| G |
Rrad |
Ras-related associated with diabetes |
|
|
ISS |
19 |
272,791 |
275,957 |
RGD:2311705 |
RGD |
| G |
Rrad |
Ras-related associated with diabetes |
|
|
ISS |
19 |
272,791 |
275,957 |
RGD:2311704 |
RGD |
| G |
RT1-Ba |
RT1 class II, locus Ba |
|
Susceptibility |
ISS |
20 |
4,697,971 |
4,702,564 |
RGD:2301814 |
RGD |
| G |
Scn1b |
sodium channel, voltage-gated, type I, beta |
|
|
IEP |
1 |
86,162,254 |
86,172,128 |
RGD:6484255 |
RGD |
| G |
Sdc2 |
syndecan 2 |
|
|
ISS |
7 |
68,290,558 |
68,405,183 |
RGD:2311706 |
RGD |
| G |
Sdc4 |
syndecan 4 |
|
|
ISS |
3 |
155,446,138 |
155,464,825 |
RGD:2311707 |
RGD |
| G |
Sell |
selectin L |
|
No_Association |
ISS |
13 |
79,827,342 |
79,845,296 |
RGD:7175303 |
RGD |
| G |
Selp |
selectin P |
|
|
ISS |
13 |
79,886,614 |
79,922,180 |
RGD:2312303 |
RGD |
| G |
Serpina12 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
|
|
ISS |
6 |
128,086,068 |
128,100,843 |
RGD:1547845 |
RGD |
| G |
Serpinc1 |
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
|
|
ISS |
13 |
76,548,456 |
76,562,724 |
RGD:2312416 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
No_Association |
ISS |
12 |
20,931,996 |
20,942,374 |
RGD:1624959 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
|
IEP |
12 |
20,931,996 |
20,942,374 |
RGD:2316116 |
RGD |
| G |
Serpinf1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
|
ISS |
10 |
62,713,441 |
62,739,444 |
RGD:2312340 |
RGD |
| G |
Shbg |
sex hormone binding globulin |
|
Susceptibility |
ISS |
10 |
56,432,474 |
56,435,654 |
RGD:2313782 |
RGD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
|
ISS |
5 |
139,690,801 |
139,719,021 |
RGD:2312306 |
RGD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
No_Association |
ISS |
5 |
139,690,801 |
139,719,021 |
RGD:2312290 |
RGD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
No_Association |
ISS |
5 |
139,690,801 |
139,719,021 |
RGD:2312289 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
2 |
116,036,501 |
116,065,834 |
RGD:1624252 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
Susceptibility |
ISS |
2 |
116,036,501 |
116,065,834 |
RGD:2312359 |
RGD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
|
ISS |
4 |
159,210,116 |
159,221,169 |
RGD:2313602 |
RGD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
|
ISS |
10 |
56,786,705 |
56,792,209 |
RGD:2313625 |
RGD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
|
ISS |
10 |
56,786,705 |
56,792,209 |
RGD:1625188 |
RGD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
|
ISS |
10 |
56,786,705 |
56,792,209 |
RGD:7240710 |
OMIM |
| G |
Slc30a8 |
solute carrier family 30 (zinc transporter), member 8 |
|
|
ISS |
7 |
88,583,770 |
88,617,145 |
RGD:7240710 |
OMIM |
| G |
Slc9a1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
|
IEP |
5 |
151,680,696 |
151,748,460 |
RGD:6771327 |
RGD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
|
ISS |
10 |
107,958,468 |
107,959,330 |
RGD:2313790 |
RGD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
|
ISS |
10 |
107,958,468 |
107,959,330 |
RGD:2313788 |
RGD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
|
ISS |
11 |
29,810,766 |
29,816,342 |
RGD:2312363 |
RGD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
|
ISS |
11 |
29,810,766 |
29,816,342 |
RGD:2312364 |
RGD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
|
ISS |
11 |
29,810,766 |
29,816,342 |
RGD:1581216 |
RGD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
|
ISS |
1 |
41,862,997 |
41,870,327 |
RGD:2312364 |
RGD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
|
ISS |
14 |
63,381,447 |
63,387,180 |
RGD:1581225 |
RGD |
| G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
|
Resistance |
ISS |
1 |
245,419,532 |
245,527,846 |
RGD:1642744 |
RGD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
|
ISS |
10 |
106,641,509 |
106,645,579 |
RGD:2311390 |
RGD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
|
ISS |
3 |
148,157,256 |
148,170,524 |
RGD:1601373 |
RGD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
|
IPM |
3 |
148,157,256 |
148,170,524 |
RGD:2307340 |
RGD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
|
IEP |
17 |
3,845,190 |
3,879,165 |
RGD:4891894 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
Susceptibility |
ISS |
10 |
46,461,684 |
46,483,646 |
RGD:2308809 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
IEP |
10 |
46,461,684 |
46,483,646 |
RGD:2308802 |
RGD |
| G |
Srebf1_v2 |
sterol regulatory element binding factor 1, variant 2 |
|
|
IEP |
|
|
|
RGD:2308802 |
RGD |
| G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
|
ISS |
7 |
120,522,511 |
120,580,212 |
RGD:1581419 |
RGD |
| G |
Star |
steroidogenic acute regulatory protein |
|
|
IEP |
16 |
70,642,580 |
70,647,203 |
RGD:4889107 |
RGD |
| G |
Tcf4 |
transcription factor 4 |
|
|
ISS |
18 |
66,135,863 |
66,359,984 |
RGD:7240710 |
OMIM |
| G |
Tcf7l2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
|
ISS |
1 |
262,031,823 |
262,226,710 |
RGD:2312433 |
RGD |
| G |
Tcf7l2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
|
IEP |
1 |
262,031,823 |
262,226,710 |
RGD:2312454 |
RGD |
| G |
Tcf7l2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
Susceptibility |
ISS |
1 |
262,031,823 |
262,226,710 |
RGD:2312453 |
RGD |
| G |
Tcf7l2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
|
ISS |
1 |
262,031,823 |
262,226,710 |
RGD:7240710 |
OMIM |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:2306740 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
IEP |
8 |
120,593,595 |
120,680,453 |
RGD:1601600 |
RGD |
| G |
Thbd |
thrombomodulin |
|
|
ISS |
3 |
137,158,955 |
137,162,607 |
RGD:2312457 |
RGD |
| G |
Thbd |
thrombomodulin |
|
Disease_progression |
ISS |
3 |
137,158,955 |
137,162,607 |
RGD:2312458 |
RGD |
| G |
Thbd |
thrombomodulin |
|
|
IEP |
3 |
137,158,955 |
137,162,607 |
RGD:1601648 |
RGD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
|
ISS |
X |
12,542,496 |
12,547,094 |
RGD:1580148 |
RGD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
|
ISS |
7 |
19,677,144 |
19,727,072 |
RGD:2312470 |
RGD |
| G |
Tjp1 |
tight junction protein 1 |
|
|
ISS |
1 |
119,684,774 |
119,750,532 |
RGD:2325150 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:2312492 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:2312484 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:2312680 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
No_Association |
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:2312494 |
RGD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
Severity |
ISS |
7 |
90,606,424 |
90,634,431 |
RGD:7205512 |
RGD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
|
IEP |
4 |
162,172,563 |
162,185,252 |
RGD:5130987 |
RGD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
|
ISS |
19 |
26,527,548 |
26,535,621 |
RGD:2313631 |
RGD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
|
IEP |
1 |
157,925,514 |
157,928,222 |
RGD:7175300 |
RGD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
|
IED |
1 |
157,925,514 |
157,928,222 |
RGD:2313517 |
RGD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
|
ISS |
1 |
157,925,514 |
157,928,222 |
RGD:2313630 |
RGD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
No_Association |
ISS |
1 |
157,925,514 |
157,928,222 |
RGD:2313525 |
RGD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
No_Association |
ISS |
1 |
157,896,001 |
157,909,608 |
RGD:2313522 |
RGD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
|
ISS |
1 |
157,896,001 |
157,909,608 |
RGD:1625189 |
RGD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
|
ISS |
1 |
157,896,001 |
157,909,608 |
RGD:2313630 |
RGD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
Susceptibility |
ISS |
1 |
157,896,001 |
157,909,608 |
RGD:2313523 |
RGD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
|
ISS |
1 |
157,896,001 |
157,909,608 |
RGD:2313511 |
RGD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
|
IED |
1 |
157,896,001 |
157,909,608 |
RGD:2313517 |
RGD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
|
ISS |
1 |
157,896,001 |
157,909,608 |
RGD:2313521 |
RGD |
| G |
Usf1 |
upstream transcription factor 1 |
|
Susceptibility |
ISS |
13 |
87,336,705 |
87,344,466 |
RGD:2313792 |
RGD |
| G |
Usf1 |
upstream transcription factor 1 |
|
|
ISS |
13 |
87,336,705 |
87,344,466 |
RGD:2313793 |
RGD |
| G |
Usf1 |
upstream transcription factor 1 |
|
No_Association |
ISS |
13 |
87,336,705 |
87,344,466 |
RGD:2313794 |
RGD |
| G |
Uts2 |
urotensin 2 |
|
|
ISS |
5 |
168,143,315 |
168,148,700 |
RGD:2306806 |
RGD |
| G |
Uts2 |
urotensin 2 |
|
Susceptibility |
ISS |
5 |
168,143,315 |
168,148,700 |
RGD:2306807 |
RGD |
| G |
Uts2 |
urotensin 2 |
|
|
ISS |
5 |
168,143,315 |
168,148,700 |
RGD:2306799 |
RGD |
| G |
Uts2 |
urotensin 2 |
|
|
ISS |
5 |
168,143,315 |
168,148,700 |
RGD:2306785 |
RGD |
| G |
Uts2r |
urotensin 2 receptor |
|
|
ISS |
10 |
110,394,782 |
110,395,942 |
RGD:2306785 |
RGD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
|
ISS |
2 |
212,277,654 |
212,297,376 |
RGD:2312765 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
|
IEA |
7 |
136,567,614 |
136,617,280 |
RGD:1331525 |
RGD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
ISS |
9 |
10,520,730 |
10,536,071 |
RGD:2313728 |
RGD |
| G |
Wfs1 |
Wolfram syndrome 1 (wolframin) |
|
|
ISS |
14 |
79,379,680 |
79,404,003 |
RGD:7240710 |
OMIM |
| Q |
Bw115 |
Body weight QTL 115 |
|
|
IED |
1 |
240,980,321 |
267,110,921 |
RGD:61072 |
RGD |
| Q |
Bw116 |
Body weight QTL 116 |
|
|
QTM |
1 |
229,876,870 |
267,593,558 |
RGD:619678 |
RGD |
| Q |
Bw119 |
Body weight QTL 119 |
|
|
IAGP |
7 |
28,674,040 |
32,004,684 |
RGD:619678 |
RGD |
| Q |
Bw120 |
Body weight QTL 120 |
|
|
IED |
12 |
12,770,194 |
42,387,195 |
RGD:61021 |
RGD |
| Q |
Bw123 |
Body weight QTL 123 |
|
|
IED |
1 |
229,633,779 |
267,910,886 |
RGD:1599587 |
RGD |
| Q |
Gluco13 |
Glucose level QTL 13 |
|
|
IED |
1 |
133,566,530 |
163,141,556 |
RGD:631173 |
RGD |
| Q |
Gluco14 |
Glucose level QTL 14 |
|
|
IED |
2 |
214,988,814 |
227,924,156 |
RGD:631173 |
RGD |
| Q |
Gluco15 |
Glucose level QTL 15 |
|
|
IED |
X |
13,041,853 |
43,167,410 |
RGD:631173 |
RGD |
| Q |
Gluco3 |
Glucose level QTL 3 |
|
|
IAGP |
12 |
1 |
12,240,883 |
RGD:61078 |
RGD |
| Q |
Gluco4 |
Glucose level QTL 4 |
|
|
IAGP |
4 |
1 |
28,615,362 |
RGD:61078 |
RGD |
| Q |
Gluco5 |
Glucose level QTL 5 |
|
|
IAGP |
|
|
|
RGD:61078 |
RGD |
| Q |
Gluco57 |
Glucose level QTL 57 |
|
|
IAGP |
1 |
235,098,616 |
252,340,527 |
RGD:2316856 |
RGD |
| Q |
Gluco58 |
Glucose level QTL 58 |
|
|
IAGP |
4 |
6,690,606 |
185,398,530 |
RGD:2316856 |
RGD |
| Q |
Gluco59 |
Glucose level QTL 59 |
|
|
IAGP |
5 |
17,517,235 |
119,332,868 |
RGD:2316856 |
RGD |
| Q |
Gluco60 |
Glucose level QTL 60 |
|
|
IAGP |
10 |
14,721,135 |
154,166,503 |
RGD:2316856 |
RGD |
| Q |
Insul2 |
Insulin level QTL 2 |
|
|
IED |
20 |
6,880,472 |
18,245,770 |
RGD:69703 |
RGD |
| Q |
Niddm1 |
Non-insulin dependent diabetes mellitus QTL 1 |
|
|
IED |
1 |
224,426,266 |
252,340,527 |
RGD:61082 |
RGD |
| Q |
Niddm10 |
Non-insulin dependent diabetes mellitus QTL 10 |
|
|
IED |
5 |
1 |
4,291,301 |
RGD:61061 |
RGD |
| Q |
Niddm11 |
Non-insulin dependent diabetes mellitus QTL 11 |
|
|
IED |
|
|
|
RGD:61061 |
RGD |
| Q |
Niddm12 |
Non-insulin dependent diabetes mellitus QTL 12 |
|
|
IED |
17 |
60,586,065 |
71,214,851 |
RGD:61061 |
RGD |
| Q |
Niddm14 |
Non-insulin dependent diabetes mellitus QTL 14 |
|
|
IED |
7 |
90,478,161 |
135,478,161 |
RGD:61072 |
RGD |
| Q |
Niddm15 |
Non-insulin dependent diabetes mellitus QTL 15 |
|
|
IED |
14 |
1,764,386 |
12,386,683 |
RGD:61072 |
RGD |
| Q |
Niddm16 |
Non-insulin dependent diabetes mellitus QTL 16 |
|
|
IED |
X |
36,612,231 |
81,612,231 |
RGD:70858 |
RGD |
| Q |
Niddm19 |
Non-insulin dependent diabetes mellitus QTL 19 |
|
|
IED |
7 |
68,162,496 |
143,002,779 |
RGD:69691 |
RGD |
| Q |
Niddm2 |
Non-insulin dependent diabetes mellitus QTL 2 |
|
|
IED |
2 |
152,256,313 |
197,256,313 |
RGD:61082 |
RGD |
| Q |
Niddm20 |
Non-insulin dependent diabetes mellitus QTL 20 |
|
|
IED |
14 |
1,764,386 |
18,915,962 |
RGD:69691 |
RGD |
| Q |
Niddm21 |
Non-insulin dependent diabetes mellitus QTL 21 |
|
|
IED |
8 |
3,039,822 |
61,462,321 |
RGD:61021 |
RGD |
| Q |
Niddm22 |
Non-insulin dependent diabetes mellitus QTL 22 |
|
|
IED |
11 |
61,504,483 |
84,560,092 |
RGD:69696 |
RGD |
| Q |
Niddm23 |
Non-insulin dependent diabetes mellitus QTL 23 |
|
|
IED |
1 |
94,473,940 |
203,416,143 |
RGD:69696 |
RGD |
| Q |
Niddm24 |
Non-insulin dependent diabetes mellitus QTL 24 |
|
|
IED |
1 |
247,322,146 |
267,111,153 |
RGD:69696 |
RGD |
| Q |
Niddm25 |
Non-insulin dependent diabetes mellitus QTL 25 |
|
|
IED |
5 |
1 |
138,272,129 |
RGD:69696 |
RGD |
| Q |
Niddm26 |
Non-insulin dependent diabetes mellitus QTL 26 |
|
|
IED |
9 |
18,347,567 |
84,432,994 |
RGD:69696 |
RGD |
| Q |
Niddm27 |
Non-insulin dependent diabetes mellitus QTL 27 |
|
|
IED |
12 |
18,937,438 |
39,323,046 |
RGD:69696 |
RGD |
| Q |
Niddm28 |
Non-insulin dependent diabetes mellitus QTL 28 |
|
|
IED |
14 |
42,599,990 |
81,222,938 |
RGD:69696 |
RGD |
| Q |
Niddm29 |
Non-insulin dependent diabetes mellitus QTL 29 |
|
|
IED |
16 |
19,510,772 |
80,047,126 |
RGD:69696 |
RGD |
| Q |
Niddm3 |
Non-insulin dependent diabetes mellitus QTL 3 |
|
|
IED |
10 |
67,678,060 |
86,316,831 |
RGD:61082 |
RGD |
| Q |
Niddm31 |
Non-insulin dependent diabetes mellitus QTL 31 |
|
|
IED |
7 |
20,307,479 |
28,488,710 |
RGD:69696 |
RGD |
| Q |
Niddm32 |
Non-insulin dependent diabetes mellitus QTL 32 |
|
|
IED |
17 |
28,303,886 |
59,104,944 |
RGD:69696 |
RGD |
| Q |
Niddm35 |
Non-insulin dependent diabetes mellitus QTL 35 |
|
|
IED |
1 |
190,677,683 |
235,677,683 |
RGD:619688 |
RGD |
| Q |
Niddm36 |
Non-insulin dependent diabetes mellitus QTL 36 |
|
|
IED |
1 |
235,677,683 |
240,980,142 |
RGD:619688 |
RGD |
| Q |
Niddm37 |
Non-insulin dependent diabetes mellitus QTL 37 |
|
|
QTM |
14 |
12,386,493 |
102,509,397 |
RGD:619676 |
RGD |
| Q |
Niddm38 |
Non-insulin dependent diabetes mellitus QTL 38 |
|
|
QTM |
19 |
10,762,811 |
24,725,428 |
RGD:619676 |
RGD |
| Q |
Niddm39 |
Non-insulin dependent diabetes mellitus QTL 39 |
|
|
QTM |
3 |
93,894,678 |
161,985,069 |
RGD:619676 |
RGD |
| Q |
Niddm4 |
Non-insulin dependent diabetes mellitus QTL 4 |
|
|
IED |
1 |
212,121,314 |
240,980,321 |
RGD:61083 |
RGD |
| Q |
Niddm40 |
Non-insulin dependent diabetes mellitus QTL 40 |
|
|
QTM |
1 |
139,026,999 |
167,337,781 |
RGD:619671 |
RGD |
| Q |
Niddm41 |
Non-insulin dependent diabetes mellitus QTL 41 |
|
|
IED |
17 |
1 |
43,786,390 |
RGD:619671 |
RGD |
| Q |
Niddm45 |
Non-insulin dependent diabetes mellitus QTL 45 |
|
|
QTM |
1 |
146,971,983 |
176,854,992 |
RGD:619678 |
RGD |
| Q |
Niddm49 |
Non-insulin dependent diabetes mellitus QTL 49 |
|
|
IAGP |
10 |
92,782,172 |
101,848,683 |
RGD:619678 |
RGD |
| Q |
Niddm50 |
Non-insulin dependent diabetes mellitus QTL 50 |
|
|
QTM |
11 |
43,157,054 |
68,234,781 |
RGD:619678 |
RGD |
| Q |
Niddm58 |
Non-insulin dependent diabetes mellitus QTL 58 |
|
|
IAGP |
1 |
230,411,091 |
267,593,558 |
RGD:619683 |
RGD |
| Q |
Niddm59 |
Non-insulin dependent diabetes mellitus QTL 59 |
|
|
IAGP |
1 |
248,583,506 |
266,234,812 |
RGD:734465 |
RGD |
| Q |
Niddm6 |
Non-insulin dependent diabetes mellitus QTL 6 |
|
|
IED |
16 |
4,304,396 |
52,304,351 |
RGD:61021 |
RGD |
| Q |
Niddm61 |
Non-insulin dependent diabetes mellitus QTL 61 |
|
|
IAGP |
8 |
38,003,289 |
103,665,018 |
RGD:1300044 |
RGD |
| Q |
Niddm62 |
Non-insulin dependent diabetes mellitus QTL 62 |
|
|
IAGP |
2 |
156,142,685 |
210,636,169 |
RGD:1302801 |
RGD |
| Q |
Niddm64 |
Non-insulin dependent diabetes mellitus QTL 64 |
|
|
IED |
1 |
254,291,806 |
254,810,043 |
RGD:1599587 |
RGD |
| Q |
Niddm65 |
Non-insulin dependent diabetes mellitus QTL 65 |
|
|
IED |
1 |
255,386,328 |
255,970,652 |
RGD:1599587 |
RGD |
| Q |
Niddm66 |
Non-insulin dependent diabetes mellitus QTL 66 |
|
|
IED |
1 |
259,866,528 |
260,641,846 |
RGD:1599587 |
RGD |
| Q |
Niddm7 |
Non-insulin dependent diabetes mellitus QTL 7 |
|
|
IED |
1 |
198,139,596 |
243,139,596 |
RGD:61061 |
RGD |
| Q |
Niddm8 |
Non-insulin dependent diabetes mellitus QTL 8 |
|
|
IED |
2 |
181,214,853 |
182,740,242 |
RGD:61061 |
RGD |
| Q |
Niddm9 |
Non-insulin dependent diabetes mellitus QTL 9 |
|
|
IED |
|
|
|
RGD:61061 |
RGD |
| Q |
Pancm1 |
Pancreatic morphology QTL 1 |
|
|
IED |
1 |
186,391,887 |
220,639,539 |
RGD:61083 |
RGD |
| Q |
Pancm2 |
Pancreatic morphology QTL 2 |
|
|
IAGP |
10 |
81,350,126 |
126,350,126 |
RGD:4889455 |
RGD |
| Q |
Pancm5 |
Pancreatic morphology QTL 5 |
|
|
IED |
14 |
32,584,630 |
86,587,723 |
RGD:69697 |
RGD |
| Q |
Pur21 |
Proteinuria QTL 21 |
|
|
IAGP |
5 |
62,098,775 |
119,332,868 |
RGD:2316856 |
RGD |
| Q |
Pur22 |
Proteinuria QTL 22 |
|
|
IAGP |
7 |
72,552,109 |
120,746,007 |
RGD:2316856 |
RGD |
| Q |
Rf57 |
Renal function QTL 57 |
|
|
IAGP |
5 |
62,098,775 |
94,515,803 |
RGD:2316856 |
RGD |
| Q |
Rf58 |
Renal function QTL 58 |
|
|
IAGP |
7 |
72,552,109 |
120,746,007 |
RGD:2316856 |
RGD |
| Q |
Scl66 |
Serum cholesterol level QTL 66 |
|
|
IAGP |
8 |
32,203,499 |
110,106,272 |
RGD:2316856 |
RGD |
| Q |
Scort2 |
Serum corticosterone level QTL 2 |
|
|
IAGP |
1 |
80,851,478 |
125,851,478 |
RGD:4889455 |
RGD |
| Q |
Stl24 |
Serum triglyceride level QTL 24 |
|
|
IAGP |
7 |
72,552,109 |
120,746,007 |
RGD:2316856 |
RGD |
| S |
BBDR.LA-(D5Rat98-D5Rat233)/Rhw |
|
|
|
IED |
5 |
100,017,060 |
124,932,061 |
RGD:6893459 |
RGD |
| S |
CRDH |
Cohen Rosenthal Diabetic Hypertensive |
|
Model |
TAS |
|
|
|
RGD:1354689 |
RGD |
| S |
Crl:ZUC-Leprfa |
Zucker rats |
|
|
QTM |
|
|
|
RGD:1354693 |
RGD |
| S |
F344.GK-(D1Got251-D1Gpam-1)/Swe |
|
|
|
IAGP |
1 |
260,641,680 |
260,641,846 |
RGD:2316628 |
RGD |
| S |
F344.GK-(D1Swe8-D1Gpam-1)/Swe |
|
|
|
IAGP |
1 |
259,866,528 |
259,866,737 |
RGD:2316628 |
RGD |
| S |
GK/KyoSwe |
Goto Kakizaki |
|
|
TAS |
|
|
|
RGD:1303373 |
RGD |
| S |
GK/KyoSwe |
Goto Kakizaki |
|
|
IED |
|
|
|
RGD:61061 |
RGD |
| S |
GK/Ox |
|
|
Model |
IAGP |
|
|
|
RGD:4889455 |
RGD |
| S |
LEW-Tg(FH1t(Insr)UTG)4Hrjb |
|
|
|
TAS |
|
|
|
RGD:2314405 |
RGD |
| S |
LEW-Tg(FH1t(Insr)UTG)87Hrjb |
|
|
|
TAS |
|
|
|
RGD:2314405 |
RGD |
| S |
OLETF |
Otsuka Long-Evans Tokushima fatty |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
OLETF/Got |
Otsuka Long Evans Tokushima |
|
|
TAS |
|
|
|
RGD:619679 |
RGD |
| S |
SD-Tg(Ins2-IAPP)Soel |
|
|
Model |
IED |
|
|
|
RGD:2313576 |
RGD |
| S |
SHR/OlaIpcv-mtBN/Crl |
|
|
Model |
IED |
|
|
|
RGD:1627567 |
RGD |
Diabetic Angiopathies
|
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
|
IPM |
6 |
129,760,129 |
129,762,545 |
RGD:7241570 |
RGD |
| G |
Cd28 |
Cd28 molecule |
|
|
ISS |
9 |
59,342,273 |
59,367,743 |
RGD:2307197 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
ISS |
X |
141,925,019 |
141,937,183 |
RGD:2314223 |
RGD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
Susceptibility |
ISS |
4 |
153,503,576 |
153,516,423 |
RGD:2306558 |
RGD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
|
ISS |
2 |
218,371,050 |
218,382,645 |
RGD:2313868 |
RGD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
|
ISS |
2 |
218,371,050 |
218,382,645 |
RGD:2313861 |
RGD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
|
ISS |
1 |
238,259,443 |
238,274,745 |
RGD:2315753 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
13 |
77,472,950 |
77,480,210 |
RGD:2315753 |
RGD |
| G |
Fn1 |
fibronectin 1 |
|
|
IED |
9 |
70,702,181 |
70,771,155 |
RGD:1601179 |
RGD |
| G |
Gp1ba |
glycoprotein Ib (platelet), alpha polypeptide |
|
|
ISS |
10 |
57,519,338 |
57,522,204 |
RGD:7242686 |
RGD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
|
ISS |
|
|
|
RGD:1600708 |
RGD |
| G |
Gsr |
glutathione reductase |
|
|
ISS |
16 |
62,255,562 |
62,298,458 |
RGD:1600708 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:2306988 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
IED |
8 |
20,040,177 |
20,051,939 |
RGD:2313473 |
RGD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
|
ISS |
14 |
87,950,222 |
87,955,289 |
RGD:1625238 |
RGD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
|
ISS |
15 |
32,493,852 |
32,503,077 |
RGD:1582581 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IPM |
10 |
65,036,884 |
65,072,453 |
RGD:2313210 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:4891384 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IEP |
4 |
6,158,847 |
6,179,441 |
RGD:4891384 |
RGD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
|
ISS |
10 |
96,056,220 |
96,057,232 |
RGD:2311657 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
ISS |
16 |
73,711,323 |
73,736,328 |
RGD:2311663 |
RGD |
| G |
Pon1 |
paraoxonase 1 |
|
|
ISS |
4 |
29,936,314 |
29,964,821 |
RGD:2313270 |
RGD |
| G |
Pon2 |
paraoxonase 2 |
|
|
ISS |
4 |
30,033,229 |
30,068,643 |
RGD:1580218 |
RGD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
|
ISS |
11 |
29,810,766 |
29,816,342 |
RGD:1600708 |
RGD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
|
IEP |
10 |
40,809,730 |
40,831,481 |
RGD:2300063 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
Susceptibility |
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:2313255 |
RGD |
Diabetic Foot
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686889 |
RGD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
Disease_progression |
ISS |
13 |
88,702,243 |
88,703,153 |
RGD:6906887 |
RGD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
|
ISS |
20 |
35,409,815 |
35,422,262 |
RGD:7207269 |
RGD |
| G |
Il15 |
interleukin 15 |
|
|
ISS |
19 |
27,487,268 |
27,498,973 |
RGD:2313575 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
ISS |
16 |
73,711,323 |
73,736,328 |
RGD:2311669 |
RGD |
Diabetic Nephropathies
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686409 |
RGD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
|
ISS |
16 |
69,163,620 |
69,166,384 |
RGD:5684403 |
RGD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
|
IEP |
|
|
|
RGD:6903847 |
RGD |
| G |
Alb |
albumin |
|
|
IEP |
14 |
19,126,935 |
19,142,214 |
RGD:2306882 |
RGD |
| G |
Apoa2 |
apolipoprotein A-II |
|
|
ISS |
13 |
87,114,734 |
87,116,372 |
RGD:2313958 |
RGD |
| G |
Apob |
apolipoprotein B |
|
|
ISS |
6 |
31,508,060 |
31,548,083 |
RGD:2313979 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
ISS |
1 |
79,003,634 |
79,006,387 |
RGD:6902935 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
Susceptibility |
ISS |
1 |
79,003,634 |
79,006,387 |
RGD:6903840 |
RGD |
| G |
Arg2 |
arginase type II |
|
|
ISS |
6 |
101,901,653 |
101,928,282 |
RGD:6902923 |
RGD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
|
ISS |
6 |
129,760,129 |
129,762,545 |
RGD:7241550 |
RGD |
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
Susceptibility |
ISS |
6 |
129,744,781 |
129,748,851 |
RGD:2313335 |
RGD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
|
IPM |
|
|
|
RGD:4891134 |
RGD |
| G |
Becn1 |
beclin 1, autophagy related |
|
|
IEP |
10 |
90,317,957 |
90,333,329 |
RGD:6483069 |
RGD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
|
ISS |
2 |
180,482,313 |
180,483,290 |
RGD:7207424 |
RGD |
| G |
Cat |
catalase |
|
|
IEP |
3 |
88,654,077 |
88,686,212 |
RGD:7205662 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
Disease_progression |
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:2306982 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IEP |
10 |
70,256,263 |
70,258,061 |
RGD:2306980 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
Susceptibility |
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:2306991 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IEP |
10 |
70,256,263 |
70,258,061 |
RGD:2306989 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
Disease_progression |
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:2306979 |
RGD |
| G |
Cpb2 |
carboxypeptidase B2 (plasma) |
|
Susceptibility |
ISS |
15 |
56,104,920 |
56,154,321 |
RGD:7243116 |
RGD |
| G |
Cpb2 |
carboxypeptidase B2 (plasma) |
|
|
ISS |
15 |
56,104,920 |
56,154,321 |
RGD:7243123 |
RGD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
Disease_progression |
ISS |
13 |
88,702,243 |
88,703,153 |
RGD:6906965 |
RGD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
|
ISS |
13 |
88,702,243 |
88,703,153 |
RGD:6906967 |
RGD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
Susceptibility |
ISS |
7 |
113,043,365 |
113,049,779 |
RGD:2307295 |
RGD |
| G |
Dcn |
decorin |
|
|
ISS |
7 |
35,004,234 |
35,045,191 |
RGD:2311415 |
RGD |
| G |
Egf |
epidermal growth factor |
|
|
ISS |
2 |
227,103,900 |
227,195,062 |
RGD:6906912 |
RGD |
| G |
Eng |
endoglin |
|
|
ISS |
|
|
|
RGD:2313795 |
RGD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
|
ISS |
1 |
21,223,678 |
21,287,411 |
RGD:6906926 |
RGD |
| G |
F2 |
coagulation factor II |
|
Disease_progression |
ISS |
3 |
76,005,318 |
76,018,603 |
RGD:6893574 |
RGD |
| G |
F2 |
coagulation factor II |
|
|
ISS |
3 |
76,005,318 |
76,018,603 |
RGD:6893575 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
13 |
77,472,950 |
77,480,210 |
RGD:2315705 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2315842 |
RGD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
|
ISS |
12 |
7,858,092 |
8,035,966 |
RGD:2313731 |
RGD |
| G |
Fuca1 |
fucosidase, alpha-L- 1, tissue |
|
|
ISS |
5 |
154,703,722 |
154,720,971 |
RGD:2315943 |
RGD |
| G |
Ghr |
growth hormone receptor |
|
|
ISS |
2 |
52,496,517 |
52,658,066 |
RGD:2307370 |
RGD |
| G |
Ghr |
growth hormone receptor |
|
Susceptibility |
ISS |
2 |
52,496,517 |
52,658,066 |
RGD:2307369 |
RGD |
| G |
Ghr |
growth hormone receptor |
|
|
IEP |
2 |
52,496,517 |
52,658,066 |
RGD:2307368 |
RGD |
| G |
Ghr |
growth hormone receptor |
|
|
IPM |
2 |
52,496,517 |
52,658,066 |
RGD:2307364 |
RGD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
|
ISS |
|
|
|
RGD:2306609 |
RGD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
|
IEP |
3 |
154,459,863 |
154,482,825 |
RGD:2301838 |
RGD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
|
ISS |
8 |
43,784,035 |
43,787,760 |
RGD:7242762 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:4145414 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
IEP |
1 |
202,906,624 |
202,915,231 |
RGD:5510022 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
ISS |
1 |
202,906,624 |
202,915,231 |
RGD:5510019 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
IEP |
1 |
202,906,624 |
202,915,231 |
RGD:5510019 |
RGD |
| G |
Il10 |
interleukin 10 |
|
Susceptibility |
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:2308943 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:7175266 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
No_Association |
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:6909120 |
RGD |
| G |
Ins2 |
insulin 2 |
|
Resistance |
IED |
1 |
202,935,548 |
202,936,379 |
RGD:6902908 |
RGD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
|
IED |
8 |
20,259,178 |
20,266,351 |
RGD:6893386 |
RGD |
| G |
Lamb2 |
laminin, beta 2 |
|
|
IEP |
|
|
|
RGD:7207449 |
RGD |
| G |
Lep |
leptin |
|
|
ISS |
4 |
55,943,837 |
55,945,938 |
RGD:6907074 |
RGD |
| G |
Lpl |
lipoprotein lipase |
|
Resistance |
ISS |
16 |
22,533,105 |
22,556,905 |
RGD:2306755 |
RGD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
|
ISS |
20 |
3,657,842 |
3,659,848 |
RGD:2313255 |
RGD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
No_Association |
ISS |
5 |
165,112,850 |
165,126,885 |
RGD:6893576 |
RGD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
Susceptibility |
ISS |
5 |
165,112,850 |
165,126,885 |
RGD:6893524 |
RGD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
|
IED |
3 |
58,366,693 |
58,394,116 |
RGD:6893386 |
RGD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
|
IPM |
17 |
11,494,463 |
11,811,654 |
RGD:4891134 |
RGD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
|
ISS |
12 |
16,151,045 |
16,172,412 |
RGD:2311649 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISS |
7 |
118,244,385 |
118,262,021 |
RGD:2311646 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
IPM |
4 |
151,492,220 |
151,617,331 |
RGD:2301862 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7242045 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7242027 |
RGD |
| G |
Prss1 |
protease, serine, 1 (trypsin 1) |
|
|
ISS |
4 |
69,185,877 |
69,189,080 |
RGD:2324899 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IPM |
13 |
64,427,288 |
64,432,978 |
RGD:5688268 |
RGD |
| G |
Selp |
selectin P |
|
Severity |
ISS |
13 |
79,886,614 |
79,922,180 |
RGD:2312302 |
RGD |
| G |
Selp |
selectin P |
|
|
IEP |
13 |
79,886,614 |
79,922,180 |
RGD:2312294 |
RGD |
| G |
Serpinb7 |
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
|
|
ISS |
13 |
13,464,818 |
13,506,372 |
RGD:7207378 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
|
IEP |
12 |
20,931,996 |
20,942,374 |
RGD:1580123 |
RGD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
|
ISS |
5 |
139,690,801 |
139,719,021 |
RGD:2312305 |
RGD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
|
ISS |
1 |
41,862,997 |
41,870,327 |
RGD:7175540 |
RGD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
|
IEP |
10 |
40,809,730 |
40,831,481 |
RGD:2300072 |
RGD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
IED |
|
|
|
RGD:1581328 |
RGD |
| G |
Tcf7l2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
|
ISS |
1 |
262,031,823 |
262,226,710 |
RGD:6906926 |
RGD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
Disease_progression |
ISS |
7 |
90,606,424 |
90,634,431 |
RGD:7205493 |
RGD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
Treatment |
ISS |
7 |
90,606,424 |
90,634,431 |
RGD:7205514 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
IEP |
10 |
56,399,721 |
56,411,150 |
RGD:2290561 |
RGD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
Treatment |
ISS |
1 |
157,925,514 |
157,928,222 |
RGD:7175295 |
RGD |
| G |
Uts2 |
urotensin 2 |
|
|
IEP |
5 |
168,143,315 |
168,148,700 |
RGD:2306786 |
RGD |
| G |
Uts2 |
urotensin 2 |
|
|
ISS |
5 |
168,143,315 |
168,148,700 |
RGD:2306805 |
RGD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
|
ISS |
2 |
212,277,654 |
212,297,376 |
RGD:7241237 |
RGD |
Diabetic Neuropathies
|
| G |
Adra2b |
adrenoceptor alpha 2B |
|
|
ISS |
3 |
114,867,357 |
114,869,680 |
RGD:2313542 |
RGD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
|
IED |
4 |
61,645,438 |
61,659,530 |
RGD:1626089 |
RGD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
|
ISS |
12 |
36,081,778 |
36,116,445 |
RGD:2311150 |
RGD |
| G |
Alox15 |
arachidonate 15-lipoxygenase |
|
|
ISS |
10 |
57,185,939 |
57,194,388 |
RGD:5509623 |
RGD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
|
IPM |
6 |
129,760,129 |
129,762,545 |
RGD:5129222 |
RGD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
|
IPM |
|
|
|
RGD:4891134 |
RGD |
| G |
Casp3 |
caspase 3 |
|
|
IEP |
16 |
48,944,226 |
48,962,420 |
RGD:2311441 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:2307060 |
RGD |
| G |
Cd63 |
Cd63 molecule |
|
|
ISS |
7 |
2,208,659 |
2,211,323 |
RGD:2314203 |
RGD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
|
IED |
5 |
50,427,173 |
50,445,471 |
RGD:2314631 |
RGD |
| G |
Epo |
erythropoietin |
|
|
ISS |
12 |
19,551,768 |
19,555,208 |
RGD:2313898 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312401 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2315860 |
RGD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
|
ISS |
|
|
|
RGD:2315614 |
RGD |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
|
ISS |
4 |
149,622,566 |
149,628,111 |
RGD:2313744 |
RGD |
| G |
Hgf |
hepatocyte growth factor |
|
|
ISS |
4 |
14,864,357 |
14,932,513 |
RGD:2313570 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
ISS |
7 |
57,621,756 |
57,625,792 |
RGD:2311489 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
ISS |
7 |
24,531,669 |
24,605,742 |
RGD:2313764 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
IPM |
7 |
24,531,669 |
24,605,742 |
RGD:2306687 |
RGD |
| G |
Insr |
insulin receptor |
|
|
IED |
12 |
2,934,967 |
3,087,691 |
RGD:2307344 |
RGD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
|
IED |
20 |
6,939,249 |
7,000,378 |
RGD:2311567 |
RGD |
| G |
Mt2A |
metallothionein 2A |
|
|
ISS |
19 |
11,267,811 |
11,268,585 |
RGD:6483853 |
RGD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
|
IEP |
2 |
197,621,726 |
197,632,960 |
RGD:5508379 |
RGD |
| G |
Ngfr |
nerve growth factor receptor |
|
|
IEP |
10 |
84,262,804 |
84,281,006 |
RGD:5508379 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:2313218 |
RGD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
|
IEP |
2 |
179,838,740 |
179,855,545 |
RGD:5508379 |
RGD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
|
ISS |
13 |
96,309,670 |
96,341,486 |
RGD:5510012 |
RGD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
|
ISS |
13 |
96,309,670 |
96,341,486 |
RGD:5683915 |
RGD |
| G |
Pgf |
placental growth factor |
|
|
ISS |
6 |
109,215,540 |
109,226,122 |
RGD:6483583 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
ISS |
16 |
73,711,323 |
73,736,328 |
RGD:2311667 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IEP |
13 |
64,427,288 |
64,432,978 |
RGD:5508311 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IPM |
13 |
64,427,288 |
64,432,978 |
RGD:1642588 |
RGD |
| G |
Retn |
resistin |
|
|
ISS |
12 |
2,499,630 |
2,501,370 |
RGD:7207161 |
RGD |
| G |
Sord |
sorbitol dehydrogenase |
|
Resistance |
IED |
3 |
109,016,830 |
109,048,446 |
RGD:1601362 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
IEP |
10 |
46,461,684 |
46,483,646 |
RGD:2308808 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
IEP |
1 |
80,894,705 |
80,911,020 |
RGD:2302086 |
RGD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
|
IEP |
13 |
102,718,703 |
102,818,768 |
RGD:2302086 |
RGD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
|
IEP |
6 |
110,173,443 |
110,195,215 |
RGD:2302086 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
Susceptibility |
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:2312493 |
RGD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
Susceptibility |
ISS |
1 |
157,925,514 |
157,928,222 |
RGD:2313516 |
RGD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
Susceptibility |
ISS |
1 |
157,896,001 |
157,909,608 |
RGD:2313516 |
RGD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
|
ISS |
2 |
212,277,654 |
212,297,376 |
RGD:2312761 |
RGD |
Diabetic Retinopathy
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
IEA |
10 |
95,361,338 |
95,381,455 |
RGD:1331525 |
RGD |
| G |
Acp1 |
acid phosphatase 1, soluble |
|
|
ISS |
6 |
48,784,243 |
48,798,868 |
RGD:2313184 |
RGD |
| G |
Adm |
adrenomedullin |
|
|
ISS |
1 |
168,380,255 |
168,382,426 |
RGD:2313312 |
RGD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
|
ISS |
16 |
69,163,620 |
69,166,384 |
RGD:5684400 |
RGD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
|
IEA |
20 |
4,250,613 |
4,253,540 |
RGD:1331525 |
RGD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
|
IED |
4 |
61,645,438 |
61,659,530 |
RGD:1626080 |
RGD |
| G |
Ang |
angiogenin, ribonuclease, RNase A family, 5 |
|
|
ISS |
15 |
27,083,089 |
27,083,526 |
RGD:2307061 |
RGD |
| G |
Angpt1 |
angiopoietin 1 |
|
|
ISS |
7 |
78,195,504 |
78,451,471 |
RGD:2313818 |
RGD |
| G |
Angpt2 |
angiopoietin 2 |
|
|
IED |
16 |
75,891,757 |
75,942,255 |
RGD:2314216 |
RGD |
| G |
Angpt2 |
angiopoietin 2 |
|
|
IEP |
16 |
75,891,757 |
75,942,255 |
RGD:2314216 |
RGD |
| G |
Aoc3 |
amine oxidase, copper containing 3 (vascular adhesion protein 1) |
|
|
ISS |
10 |
90,357,094 |
90,365,040 |
RGD:2313826 |
RGD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
|
ISS |
8 |
49,233,142 |
49,233,431 |
RGD:5685692 |
RGD |
| G |
Apob |
apolipoprotein B |
|
|
ISS |
6 |
31,508,060 |
31,548,083 |
RGD:2313976 |
RGD |
| G |
Apoc3 |
apolipoprotein C-III |
|
Severity |
ISS |
|
|
|
RGD:2306768 |
RGD |
| G |
Apoh |
apolipoprotein H (beta-2-glycoprotein I) |
|
|
ISS |
10 |
97,725,088 |
97,739,213 |
RGD:2313982 |
RGD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
|
IPM |
6 |
129,760,129 |
129,762,545 |
RGD:2313334 |
RGD |
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
|
IPM |
6 |
129,744,781 |
129,748,851 |
RGD:2313334 |
RGD |
| G |
Casp3 |
caspase 3 |
|
|
IEP |
16 |
48,944,226 |
48,962,420 |
RGD:2311444 |
RGD |
| G |
Casp3 |
caspase 3 |
|
|
ISS |
16 |
48,944,226 |
48,962,420 |
RGD:2311448 |
RGD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
|
ISS |
5 |
160,704,234 |
160,721,796 |
RGD:2311244 |
RGD |
| G |
Cat |
catalase |
|
|
IEP |
3 |
88,654,077 |
88,686,212 |
RGD:5130875 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:2307061 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
Severity |
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:2307104 |
RGD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
|
IEP |
3 |
89,243,600 |
89,245,129 |
RGD:1600487 |
RGD |
| G |
Ctgf |
connective tissue growth factor |
|
|
IEP |
1 |
21,327,099 |
21,330,215 |
RGD:2314507 |
RGD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
|
ISS |
14 |
17,265,986 |
17,268,183 |
RGD:2311361 |
RGD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
Severity |
ISS |
4 |
153,503,576 |
153,516,423 |
RGD:2306559 |
RGD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
|
IEP |
19 |
52,713,150 |
52,721,609 |
RGD:2317854 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
ISS |
17 |
28,303,886 |
28,309,775 |
RGD:2313281 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
ISS |
17 |
28,303,886 |
28,309,775 |
RGD:2313279 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:1580957 |
RGD |
| G |
Eng |
endoglin |
|
|
ISS |
|
|
|
RGD:1580961 |
RGD |
| G |
Epo |
erythropoietin |
|
|
ISS |
12 |
19,551,768 |
19,555,208 |
RGD:2313890 |
RGD |
| G |
Epo |
erythropoietin |
|
|
ISS |
12 |
19,551,768 |
19,555,208 |
RGD:2313838 |
RGD |
| G |
Epo |
erythropoietin |
|
|
ISS |
12 |
19,551,768 |
19,555,208 |
RGD:2313837 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312398 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
IEP |
2 |
123,893,314 |
123,947,136 |
RGD:2315875 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2315845 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2315885 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2315844 |
RGD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
|
ISS |
12 |
7,858,092 |
8,035,966 |
RGD:2313721 |
RGD |
| G |
Fuca1 |
fucosidase, alpha-L- 1, tissue |
|
|
IEP |
5 |
154,703,722 |
154,720,971 |
RGD:2315932 |
RGD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
|
IEP |
4 |
161,282,215 |
161,286,090 |
RGD:2315975 |
RGD |
| G |
Gc |
group specific component |
|
|
ISS |
14 |
20,166,243 |
20,197,060 |
RGD:2315548 |
RGD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
|
ISS |
|
|
|
RGD:2315614 |
RGD |
| G |
Gh1 |
growth hormone 1 |
|
|
ISS |
10 |
95,692,240 |
95,694,117 |
RGD:2315688 |
RGD |
| G |
Glo1 |
glyoxalase 1 |
|
No_Association |
ISS |
20 |
8,900,984 |
8,919,001 |
RGD:7242569 |
RGD |
| G |
Hgf |
hepatocyte growth factor |
|
Disease_progression |
ISS |
4 |
14,864,357 |
14,932,513 |
RGD:2313565 |
RGD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
|
IED |
1 |
201,385,705 |
201,388,987 |
RGD:1358731 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:2313471 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:2313472 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
Susceptibility |
ISS |
7 |
24,531,669 |
24,605,742 |
RGD:1598424 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
ISS |
7 |
24,531,669 |
24,605,742 |
RGD:2313764 |
RGD |
| G |
Il10 |
interleukin 10 |
|
Susceptibility |
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:2307272 |
RGD |
| G |
Il10 |
interleukin 10 |
|
|
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:2307061 |
RGD |
| G |
Il10 |
interleukin 10 |
|
|
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:1598486 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889417 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:2307061 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:2307061 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307272 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307267 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:6902909 |
RGD |
| G |
Itga2 |
integrin, alpha 2 |
|
Severity |
ISS |
2 |
46,967,681 |
47,080,909 |
RGD:2307419 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
Spontaneous |
ISS |
19 |
15,246,036 |
15,275,061 |
RGD:1582582 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:1582616 |
RGD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
Susceptibility |
ISS |
5 |
165,112,850 |
165,126,885 |
RGD:6893525 |
RGD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
|
ISS |
2 |
197,621,726 |
197,632,960 |
RGD:7242804 |
RGD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
|
IEP |
12 |
39,812,500 |
39,869,484 |
RGD:1642141 |
RGD |
| G |
Nppa |
natriuretic peptide A |
|
|
ISS |
5 |
165,074,518 |
165,075,827 |
RGD:2313589 |
RGD |
| G |
Npr3 |
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
|
|
IEP |
2 |
61,278,264 |
61,341,460 |
RGD:1580773 |
RGD |
| G |
Pgf |
placental growth factor |
|
|
IEP |
6 |
109,215,540 |
109,226,122 |
RGD:6483775 |
RGD |
| G |
Pon1 |
paraoxonase 1 |
|
|
ISS |
4 |
29,936,314 |
29,964,821 |
RGD:2313272 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
Onset |
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:2301854 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
IEP |
14 |
64,278,115 |
64,370,912 |
RGD:5686899 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
IED |
14 |
64,278,115 |
64,370,912 |
RGD:6484532 |
RGD |
| G |
Retn |
resistin |
|
|
ISS |
12 |
2,499,630 |
2,501,370 |
RGD:7207162 |
RGD |
| G |
Serpina4 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 |
|
|
ISS |
6 |
128,133,692 |
128,142,768 |
RGD:1580289 |
RGD |
| G |
Serpinf1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
|
ISS |
10 |
62,713,441 |
62,739,444 |
RGD:2312341 |
RGD |
| G |
Serpinf1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
|
IEP |
10 |
62,713,441 |
62,739,444 |
RGD:2312348 |
RGD |
| G |
Serpinf1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
|
ISS |
10 |
62,713,441 |
62,739,444 |
RGD:2312346 |
RGD |
| G |
Serpinf1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
|
ISS |
10 |
62,713,441 |
62,739,444 |
RGD:2312337 |
RGD |
| G |
Serpinf1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
|
ISS |
10 |
62,713,441 |
62,739,444 |
RGD:2312344 |
RGD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
|
ISS |
14 |
63,381,447 |
63,387,180 |
RGD:1581298 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
|
IEP |
|
|
|
RGD:2317943 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
Onset |
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:2312487 |
RGD |
| G |
Uts2 |
urotensin 2 |
|
|
ISS |
5 |
168,143,315 |
168,148,700 |
RGD:2306795 |
RGD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
|
ISS |
2 |
212,277,654 |
212,297,376 |
RGD:2312762 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
|
ISS |
7 |
136,567,614 |
136,617,280 |
RGD:1580363 |
RGD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
ISS |
9 |
10,520,730 |
10,536,071 |
RGD:1580565 |
RGD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
ISS |
9 |
10,520,730 |
10,536,071 |
RGD:2301992 |
RGD |
| G |
Vtn |
vitronectin |
|
|
ISS |
10 |
64,609,242 |
64,612,322 |
RGD:1580818 |
RGD |
| G |
Vwf |
von Willebrand factor |
|
|
ISS |
4 |
161,723,415 |
161,854,766 |
RGD:1580648 |
RGD |
| S |
SDT/Jcl |
|
|
|
TAS |
|
|
|
RGD:631173 |
RGD |
Fetal Macrosomia
|
| G |
Lipc |
lipase, hepatic |
|
|
IEP |
8 |
75,323,442 |
75,450,353 |
RGD:2308786 |
RGD |
Hyperglycemic Hyperosmolar Nonketotic Coma
|
| S |
ZDF |
Vancouver diabetic fatty Zucker |
|
|
TAS |
|
|
|
RGD:68929 |
RGD |
Maturity-Onset Diabetes of the Young, Type 1
|
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
|
ISS |
3 |
154,459,863 |
154,482,825 |
RGD:7240710 |
OMIM |
Maturity-Onset Diabetes of the Young, Type 2
|
| G |
Gck |
glucokinase |
|
|
ISS |
14 |
86,572,518 |
86,587,723 |
RGD:7240710 |
OMIM |
Maturity-Onset Diabetes of the Young, Type 3
|
| G |
Hnf1a |
HNF1 homeobox A |
|
|
ISS |
12 |
42,919,574 |
42,945,670 |
RGD:7240710 |
OMIM |
Maturity-Onset Diabetes of the Young, Type 8, with Exocrine Dysfunction
|
| G |
Cel |
carboxyl ester lipase |
|
|
ISS |
3 |
7,541,127 |
7,549,245 |
RGD:7240710 |
OMIM |
Maturity-Onset Diabetes Of The Young, Type 9
|
| G |
Pax4 |
paired box 4 |
|
|
ISS |
4 |
55,313,500 |
55,318,995 |
RGD:7240710 |
OMIM |
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2
|
| G |
Epo |
erythropoietin |
|
|
ISS |
12 |
19,551,768 |
19,555,208 |
RGD:7240710 |
OMIM |
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:7240710 |
OMIM |
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4
|
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:7240710 |
OMIM |
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5
|
| G |
Pon1 |
paraoxonase 1 |
|
|
ISS |
4 |
29,936,314 |
29,964,821 |
RGD:7240710 |
OMIM |
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6
|
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
|
ISS |
1 |
41,862,997 |
41,870,327 |
RGD:7240710 |
OMIM |
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7
|
| G |
Hfe |
hemochromatosis |
|
|
ISS |
17 |
48,469,927 |
48,478,502 |
RGD:7240710 |
OMIM |
Renal cysts and diabetes syndrome
|
| G |
Hnf1b |
HNF1 homeobox B |
|
|
ISS |
10 |
72,081,091 |
72,187,014 |
RGD:7240710 |
OMIM |
Term paths to the root
|